<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>NeuroMolecular Medicine via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'NeuroMolecular Medicine' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=NeuroMolecular+Medicine&t=NeuroMolecular+Medicine&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 20 Mar 2010 14:41:47 +0100</lastBuildDate>
        <item>
            <title>Altered Hippocampal Synaptic Physiology in Aged Parkin-Deficient Mice</title>
            <link>http://www.medworm.com/index.php?rid=3372084&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr167015t72052765%2F</link>
            <description>We examined synaptic function in the hippocampus of aged mice deficient for the Parkinson’s disease-linked protein, parkin.
 Surprisingly, heterozygous but not homozygous parkin-deficient mice exhibited impairments in basal excitatory synaptic strength.
 Similarly heterozygous mice exhibited broad deficits in paired-pulse facilitation, while homozygous parkin-deficient mice
 exhibited more restricted deficits. In contrast to the measurements of basal synaptic function, synaptic plasticity was not
 altered in aged heterozygous parkin-deficient mice, but was enhanced in aged homozygous parkin-deficient mice, due to an absence
 of age-related decline. These findings of differential synaptic phenotypes in heterozygous vs. homozygous parkin deficiency
 suggest compensatory responses to geneti...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3372084</comments>
            <pubDate>Mon, 15 Mar 2010 18:00:02 +0100</pubDate>
            <guid isPermaLink="false">3372084</guid>        </item>
        <item>
            <title>Synonymous Polymorphisms at Splicing Regulatory Sites are Associated with CpGs in Neurodegenerative Disease-Related Genes</title>
            <link>http://www.medworm.com/index.php?rid=3191278&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F770267h602h17824%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neuronal plasticity is associated with alternative splicing and epigenetic modulation. Recent evidence reveals the association
 of cytosine methylation with alternative splicing and splicing regulatory mechanisms. Single nucleotide polymorphisms (SNPs)
 are generally less frequent in conserved coding regions and probably in splice sites, compared to non-coding regions. CpG
 polymorphisms in coding regions and splice sites and their association with splicing regulatory elements have not been investigated
 till presently. We currently analyzed the CpG variability in 28 genes (361 constitutive and 105 alternative exons and the
 corresponding splice sites) associated with neurodegenerative diseases (ND). CpG polymorphisms in the splice sites of these
 genes are particularly...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3191278</comments>
            <pubDate>Fri, 15 Jan 2010 00:47:47 +0100</pubDate>
            <guid isPermaLink="false">3191278</guid>        </item>
        <item>
            <title>Functional Alterations in Memory Networks in Early Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=3169387&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F88422603mhwj2126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The hallmark clinical symptom of early Alzheimer’s disease (AD) is episodic memory impairment. Recent functional imaging studies
 suggest that memory function is subserved by a set of distributed networks, which include both the medial temporal lobe (MTL)
 system and the set of cortical regions collectively referred to as the default network. Specific regions of the default network,
 in particular, the posteromedial cortices, including the precuneus and posterior cingulate, are selectively vulnerable to
 early amyloid deposition in AD. These regions are also thought to play a key role in both memory encoding and retrieval, and
 are strongly functionally connected to the MTL. Multiple functional magnetic resonance imaging (fMRI) studies during memory
 tasks have reveal...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3169387</comments>
            <pubDate>Tue, 12 Jan 2010 18:22:50 +0100</pubDate>
            <guid isPermaLink="false">3169387</guid>        </item>
        <item>
            <title>Homocysteine Potentiates Seizures and Cell Loss Induced by Pilocarpine Treatment</title>
            <link>http://www.medworm.com/index.php?rid=3117092&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg2n38851687n1084%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients affected by recurrent seizures frequently present increased homocysteine plasma levels in consequence of treatment
 with antiepileptic drugs. Homocysteine is proconvulsant and can affect the response to antiepileptic drugs. In addition, high
 homocysteine plasma levels represent a risk factor for cardiovascular and neurodegenerative diseases. To better define the
 role of increased homocysteine in epilepsy, we analyzed the effects of homocysteine pretreatment in the pilocarpine model
 of status epilepticus (SE), which is used to mimic temporal lobe epilepsy (TLE) in rodents. Precisely, we investigated whether a moderate hyperhomocysteinemia,
 unable to cause seizures, could sensitize rats to pilocarpine and cooperate in inducing brain lesions. We found that a s...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3117092</comments>
            <pubDate>Mon, 21 Dec 2009 23:04:59 +0100</pubDate>
            <guid isPermaLink="false">3117092</guid>        </item>
        <item>
            <title>From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure</title>
            <link>http://www.medworm.com/index.php?rid=3086955&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft643pq765436l708%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Manganism is a distinct medical condition from Parkinson’s disease. Manganese exposure scenarios in the last century generally
 have changed from the acute, high-level exposure conditions responsible for the occurrence of manganism to chronic exposure
 to much lower levels. Such chronic exposures may progressively extend the site of manganese deposition and toxicity from the
 globus pallidus to the entire area of the basal ganglia, including the substantia nigra pars compacta involved in Parkinson’s
 disease. The mechanisms of manganese neurotoxicity from chronic exposure to very low levels are not well understood, but promising
 information is based on the concept of susceptibility that may place individuals exposed to manganese at a higher risk for
 developing Par...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3086955</comments>
            <pubDate>Thu, 10 Dec 2009 15:24:27 +0100</pubDate>
            <guid isPermaLink="false">3086955</guid>        </item>
        <item>
            <title>Metal Ion Physiopathology in Neurodegenerative Disorders</title>
            <link>http://www.medworm.com/index.php?rid=3041836&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbk42216506084204%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Metal dyshomeostasis in the brain (BMD) has often been proposed as a possible cause for several neurodegenerative disorders
 (NDs). Nevertheless, the precise nature of the biochemical mechanisms of metal involvement in NDs is still largely unknown.
 Mounting evidence suggests that normal aging itself is characterized by, among other features, a significant degree of metal
 ion dysmetabolism in the brain. This is probably the result of a progressive deterioration of the metal regulatory systems
 and, at least in some cases, of life-long metal exposure and brain accumulation. Although alterations of metal metabolism
 do occur to some extent in normal aging, they appear to be highly enhanced under various neuropathological conditions, causing
 increased oxidative stress an...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3041836</comments>
            <pubDate>Sat, 28 Nov 2009 07:06:29 +0100</pubDate>
            <guid isPermaLink="false">3041836</guid>        </item>
        <item>
            <title>Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=3041837&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F601qq64v8255341j%2F</link>
            <description>We describe alterations in hippocampal plasticity, which occur in both chronic stress
 and AD including dendritic remodeling, neurogenesis, and long-term potentiation. Finally, we outline potential roles for oxidative
 stress and neurotrophic factor signaling as the key determinants of the impact of chronic stress on the plasticity of neural
 networks and AD pathogenesis.
 
	Content Type Journal ArticleCategory Review PaperDOI 10.1007/s12017-009-8107-9Authors
		Sarah M. Rothman, Laboratory of Neurosciences, National Institute on Aging Intramural Research Program Baltimore MD 21224 USAMark P. Mattson, Laboratory of Neurosciences, National Institute on Aging Intramural Research Program Baltimore MD 21224 USA
	

	
		Journal NeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084 (Sou...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3041837</comments>
            <pubDate>Fri, 27 Nov 2009 07:07:53 +0100</pubDate>
            <guid isPermaLink="false">3041837</guid>        </item>
        <item>
            <title>A Critical Role of Src-Suppressed C Kinase Substrate in Rat Astrocytes After Chronic Constriction Injury</title>
            <link>http://www.medworm.com/index.php?rid=3041838&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbp17511116261u07%2F</link>
            <description>In this study, we mainly investigated the mRNA and protein expression
 and cellular localization of SSeCKS during chronic constriction injury (CCI). Reverse transcriptase-mediated PCR and western
 blot analysis revealed that SSeCKS was present in normal whole spinal cord. It gradually increased, and reached a peak at
 2&amp;nbsp;weeks for its mRNA level and 7&amp;nbsp;days for its protein level after CCI. The protein expression of SSeCKS was further analyzed
 by immunohistochemistry. The positively stained areas for SSeCKS changed with the similar pattern to that of protein expression
 detected by immunoblotting analysis. Double immunofluorescence staining showed SSeCKS immunoreactivity was mostly co-localized
 with neurons, partly with activated astrocytes and rarely with microglia in the superfi...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3041838</comments>
            <pubDate>Wed, 25 Nov 2009 17:03:36 +0100</pubDate>
            <guid isPermaLink="false">3041838</guid>        </item>
        <item>
            <title>Association Study Between the Pericentrin (PCNT) Gene and Schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=3032246&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F50451126g7181610%2F</link>
            <description>In this study, case-controlled association analysis
 was performed to determine if the PCNT gene is implicated in SZ. Nine SNPs were analyzed in 1,477 individuals (726 patients with SZ and 751 healthy controls). No
 significant difference was observed between the controls and the patients in allelic frequencies or genotypic distributions
 of eight SNPs. Although allelic distribution of rs11702684 was different between the two groups (P&amp;nbsp;=&amp;nbsp;0.042), the difference did not reach statistical significance after permutation correction for multiple comparisons. In
 the haplotypic analysis, we could not find any significant association in our subjects, either. This gene may not play a major
 role independently in the etiology of SZ in the Japanese population.
 
	Content Type Journal Articl...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3032246</comments>
            <pubDate>Tue, 24 Nov 2009 07:16:08 +0100</pubDate>
            <guid isPermaLink="false">3032246</guid>        </item>
        <item>
            <title>HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort</title>
            <link>http://www.medworm.com/index.php?rid=3032245&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd26rj37218185474%2F</link>
            <description>In conclusion, we suggest that HTR2A may play an important role in the pathophysiology of the therapeutic response to SSRIs in Japanese MDD patients. However,
 it will be important to replicate and confirm these findings in other independent studies using large samples.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-009-8105-yAuthors
		Taro Kishi, Fujita Health University School of Medicine Department of Psychiatry Toyoake, Aichi 470-1192 JapanReiji Yoshimura, University of Occupational and Environmental Health Department of Psychiatry Kitakyushu, Fukuoka 807-8555 JapanTsuyoshi Kitajima, Fujita Health University School of Medicine Department of Psychiatry Toyoake, Aichi 470-1192 JapanTomo Okochi, Fujita Health University School of Medicine Department of Psychiatry...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3032245</comments>
            <pubDate>Tue, 24 Nov 2009 07:16:08 +0100</pubDate>
            <guid isPermaLink="false">3032245</guid>        </item>
        <item>
            <title>An Overview of APP Processing Enzymes and Products</title>
            <link>http://www.medworm.com/index.php?rid=3032247&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk398j571nr081k1t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The generation of amyloid β-peptide (Aβ) by enzymatic cleavages of the β-amyloid precursor protein (APP) has been at the center
 of Alzheimer’s disease (AD) research. While the basic process of β- and γ-secretase-mediated generation of Aβ is text book
 knowledge, new aspects of Aβ and other cleavage products have emerged in recent years. Also our understanding of the enzymes
 involved in APP proteolysis has increased dramatically. All of these discoveries contribute to a more complete understanding
 of APP processing and the physiologic and pathologic roles of its secreted and intracellular protein products. Understanding
 APP processing is important for any therapeutic strategy aimed at reducing Aβ levels in AD. In this review, we provide a concise
 descripti...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3032247</comments>
            <pubDate>Tue, 24 Nov 2009 07:16:04 +0100</pubDate>
            <guid isPermaLink="false">3032247</guid>        </item>
        <item>
            <title>Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases</title>
            <link>http://www.medworm.com/index.php?rid=2990878&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F55681m7330r3850w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A functional intracellular transport system is essential to maintain cell shape and function especially in elongated cells,
 e.g. neurons and lens fibre cells. Impaired intracellular transport has been suggested as a common pathological mechanism
 for age-related diseases characterised by protein aggregation. Here, we hypothesise that common genetic variation in the transport
 protein kinesin may influence the risk of Parkinson’s disease (PD), Alzheimer’s disease (AD) and age-related cataract. This
 case–control study involves a PD material (165 cases and 190 controls), an AD material (653 cases and 845 controls) and a
 cataract material (495 cases and 183 controls). Genetic variation in the kinesin light chain 1-encoding gene (KLC1) was tagged by six tag single n...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2990878</comments>
            <pubDate>Thu, 12 Nov 2009 18:01:18 +0100</pubDate>
            <guid isPermaLink="false">2990878</guid>        </item>
        <item>
            <title>Manganese Flux Across the Blood–Brain Barrier</title>
            <link>http://www.medworm.com/index.php?rid=2983018&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4510153088t37h7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Manganese (Mn) is essential for brain growth and metabolism, but in excess can be a neurotoxicant. The chemical form (species)
 of Mn influences its kinetics and toxicity. Significant Mn species entering the brain are the Mn2+ ion and Mn citrate which, along with Mn transferrin, enter the brain by carrier-mediated processes. Although the divalent
 metal transporter (DMT-1) was suggested to be a candidate for brain Mn uptake, brain Mn influx was not different in Belgrade
 rats, which do not express functional DMT-1, compared to controls. Brain Mn influx was not sodium dependent or dependent on
 ATP hydrolysis, but was reduced by mitochondrial energy inhibitors. Mn and Fe do not appear to compete for brain uptake. Brain
 Mn uptake appears to be mediated by a Ca uptake mec...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2983018</comments>
            <pubDate>Mon, 09 Nov 2009 19:08:42 +0100</pubDate>
            <guid isPermaLink="false">2983018</guid>        </item>
        <item>
            <title>Alzheimer’s Disease and Neuronal Network Activity</title>
            <link>http://www.medworm.com/index.php?rid=2961286&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft7u8015111144374%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The amyloid β-peptide theory of Alzheimer’s Disease has helped to advance our understanding of the disease tremendously. A
 new area of research focuses on the changes in neuronal network activity that take place and may contribute to the clinical
 and pathological picture of Alzheimer’s Disease. An apparent symptom of altered neuronal network activity in Alzheimer’s Disease
 is an increased frequency in epileptic seizures that is observed both in human patients and in mouse models of Alzheimer’s
 Disease. A root cause for altered network activity may be amyloid β itself by its ability to alter synaptic (glutamatergic)
 transmission and to impair the induction of long-term potentiation. It is on this aspect of Alzheimer’s Disease research that
 the current i...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2961286</comments>
            <pubDate>Tue, 03 Nov 2009 11:07:15 +0100</pubDate>
            <guid isPermaLink="false">2961286</guid>        </item>
        <item>
            <title>Manganese and its Role in Parkinson’s Disease: From Transport to Neuropathology</title>
            <link>http://www.medworm.com/index.php?rid=2945548&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7p577j3455431510%2F</link>
            <description>Content Type Journal ArticleCategory ErratumDOI 10.1007/s12017-009-8084-zAuthors
		Michael Aschner, Vanderbilt University Medical Center Departments of Pediatrics and Pharmacology and the Kennedy Center for Research on Human Development 2215-B Garland Avenue, 11425 MRB IV Nashville TN 37232-0414 USAKeith M. Erikson, University of North Carolina at Greensboro Department of Nutrition Greensboro NC USAElena Herrero Hernández, Oregon Health and Science University Center for Research on Occupational and Environmental, Toxicology Portland OR USARonald Tjalkens, Colorado State University Environmental and Radiological Health Sciences Fort Collins CO USA
	

	
		Journal NeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084 (Source: NeuroMolecular Medicine)</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945548</comments>
            <pubDate>Wed, 28 Oct 2009 20:36:23 +0100</pubDate>
            <guid isPermaLink="false">2945548</guid>        </item>
        <item>
            <title>Modelling Parkinson’s Disease in Drosophila</title>
            <link>http://www.medworm.com/index.php?rid=2929126&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc56l241j3401u81m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The recent discovery of a number of genes involved in familial forms of Parkinson’s disease (PD) has moved the use of model
 genetic organisms to the frontline. One avenue holding tremendous potential to find therapies against human diseases is the
 use of intact living systems where complex biological processes can be examined. Despite key differences that need to be taken
 into account when using invertebrate models such as Drosophila, there are many advantages offered by this system. The rapid generation time and the ability to easily generate transgenic
 animals together with the variety of genetic tools to control temporal and spatial expression of any given gene makes the
 fly model a very attractive system to study human neurodegenerative disorders. In this rev...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2929126</comments>
            <pubDate>Fri, 23 Oct 2009 18:48:12 +0100</pubDate>
            <guid isPermaLink="false">2929126</guid>        </item>
        <item>
            <title>Phospholipases A2 and Inflammatory Responses in the Central Nervous System</title>
            <link>http://www.medworm.com/index.php?rid=2929127&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu3v8310t558r3t77%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Phospholipases A2 (PLA2s) belong to a superfamily of enzymes responsible for hydrolyzing the sn-2 fatty acids of membrane phospholipids. These enzymes are known to play multiple roles for maintenance of membrane phospholipid
 homeostasis and for production of a variety of lipid mediators. Over 20 different types of PLA2s are present in the mammalian
 cells, and in snake and bee venom. Despite their common function in hydrolyzing fatty acids of phospholipids, they are diversely
 encoded by a number of genes and express proteins that are regulated by different mechanisms. Recent studies have focused
 on the group IV calcium-dependent cytosolic cPLA2, the group VI calcium-independent iPLA2, and the group II small molecule
 secretory sPLA2. In the central nervous system (CN...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2929127</comments>
            <pubDate>Fri, 23 Oct 2009 18:48:11 +0100</pubDate>
            <guid isPermaLink="false">2929127</guid>        </item>
        <item>
            <title>Involvement of Fc Receptors in Disorders of the Central Nervous System</title>
            <link>http://www.medworm.com/index.php?rid=2918188&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff57n24k638421155%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Immunoglobulins are proteins with a highly variable antigen-binding domain and a constant region (Fc domain) that binds to
 a cell surface receptor (FcR). Activation of FcRs in immune cells (lymphocytes, macrophages, and mast cells) triggers effector
 responses including cytokine production, phagocytosis, and degranulation. In addition to their roles in normal responses to
 infection or tissue injury, and in immune-related diseases, FcRs are increasingly recognized for their involvement in neurological
 disorders. One or more FcRs are expressed in microglia, astrocytes, oligodendrocytes, and neurons. Aberrant activation of
 FcRs in such neural cells may contribute to the pathogenesis of major neurodegenerative conditions including Alzheimer’s disease,
 Parkinson’s d...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918188</comments>
            <pubDate>Wed, 21 Oct 2009 09:02:20 +0100</pubDate>
            <guid isPermaLink="false">2918188</guid>        </item>
        <item>
            <title>No Association of VEGF Polymorphims with Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=2918189&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqk117066741l2141%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The vascular hypothesis of Alzheimer’s disease (AD) has brought the vascular endothelial growth factor (VEGF) into focus.
 The genomic region including the VEGF gene has been linked to AD and single nucleotide polymorphisms (SNPs) of the VEGF have in previous studies been associated with AD risk. To further evaluate these findings, we genotyped two SNPs in the VEGF gene (rs699947 [−2578]) and rs1570360 [−1154]) by TaqMan Allelic Discrimination in a study sample including AD patients (n&amp;nbsp;=&amp;nbsp;801) and controls (n&amp;nbsp;=&amp;nbsp;286). In a subgroup of the population these SNPs were analyzed in relation to APOE ε4 genotype, to cerebrospinal fluid biomarkers (T-tau, P-tau, and β42-Amyloid) as well as to neuropathological markers for AD (neurofibrillary tangles an...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918189</comments>
            <pubDate>Tue, 20 Oct 2009 16:30:38 +0100</pubDate>
            <guid isPermaLink="false">2918189</guid>        </item>
        <item>
            <title>Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin?</title>
            <link>http://www.medworm.com/index.php?rid=2906713&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw6w6063517423121%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurodegenerative diseases, including Alzheimer’s disease (AD), target specific and functionally connected neuronal networks,
 raising the possibility that neurodegeneration may spread through abnormal patterns of neural network activity. AD is associated
 with high levels of amyloid-β (Aβ) peptides in the brain, synaptic depression, aberrant excitatory neuronal activity, and
 cognitive decline. However, the relationships among these alterations and their underlying mechanisms are poorly understood.
 In experimental models of AD, high concentrations of pathogenic Aβ assemblies reduce glutamatergic transmission and enhance
 long-term depression at the synaptic level. At the network level, they cause dysrhythmias, including neuronal synchronization,
 epileptiform act...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2906713</comments>
            <pubDate>Fri, 16 Oct 2009 17:44:04 +0100</pubDate>
            <guid isPermaLink="false">2906713</guid>        </item>
        <item>
            <title>A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors</title>
            <link>http://www.medworm.com/index.php?rid=2896734&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq877022tvt7h248m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurologic disease promoted by microbial pathogens, sterile injury, or neurodegeneration rapidly induces innate immunity in
 adjacent healthy tissue, which in turn contributes extensively to neurologic injury. With more recent focus on innate immune
 processes, it appears that necrotic, but not apoptotic, death mechanisms provoke inflammatory responses likely due to the
 release or production of endogenous ligands that activate resident immune cells of the central nervous system. These ligands
 comprise a diverse set of proteins, nucleic acids, and glycosaminoglycans, including heat shock proteins, HMGB1, RNA, DNA,
 hyaluronan, and heparin sulfate, that stimulate innate immune mechanisms largely through Toll-like receptors (TLRs). The blockade
 of interactions between e...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2896734</comments>
            <pubDate>Wed, 14 Oct 2009 17:11:23 +0100</pubDate>
            <guid isPermaLink="false">2896734</guid>        </item>
        <item>
            <title>Paraoxonase 1 Polymorphisms Are Not Related with the Risk for Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2896735&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy647283x0p5422x7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been suggested a possible role of oxidative stress and lipid peroxidation in the inflammatory processes and in the
 pathogenesis of multiple sclerosis. Human serum paraoxonase 1 is a polymorphic enzyme encoded by the gene PON1, located in chromosome 7q21.3, that plays a major role in the metabolism of organophosporus compounds, and in the protection
 against oxidative stress. Paraoxonase-1 activity has been found decreased in the plasma of multiple sclerosis patients. An
 association between PON1 polymorphism and the risk of multiple sclerosis has been described in Italians. To investigate the possible association between
 the PON1 genotype and allelic variants of the polymorphisms L55M and Q192R and the risk for multiple sclerosis in the Spanish Caucasian
 popul...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2896735</comments>
            <pubDate>Tue, 13 Oct 2009 20:35:17 +0100</pubDate>
            <guid isPermaLink="false">2896735</guid>        </item>
        <item>
            <title>The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System</title>
            <link>http://www.medworm.com/index.php?rid=2811099&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4732481u64p4718g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The complement system is a pivotal component of the innate immune system which protects the host from infection and injury.
 Complement proteins can be induced in all cell types within the central nervous system (CNS), where the pathway seems to play
 similar roles in host defense. Complement activation produces the C5 cleavage fragment C5a, a potent inflammatory mediator,
 which recruits and activates immune cells. The primary cellular receptor for C5a, the C5a receptor (CD88), has been reported
 to be on all CNS cells, including neurons and glia, suggesting a functional role for C5a in the CNS. A second receptor for
 C5a, the C5a-like receptor 2 (C5L2), is also expressed on these cells; however, little is currently known about its potential role in the CNS. The potent...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811099</comments>
            <pubDate>Thu, 17 Sep 2009 23:13:06 +0100</pubDate>
            <guid isPermaLink="false">2811099</guid>        </item>
        <item>
            <title>The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair</title>
            <link>http://www.medworm.com/index.php?rid=2811100&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk4037p60816477q0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAS (miRNAs) have been suggested to play important roles in the central nervous system during development as well as
 disease. miRNAs appear to be dysregulated in a number of neurodegenerative diseases, developmental disorders, and as a result
 of stroke. Each miRNA has the ability to regulate hundreds of messenger RNA transcripts, both by causing degradation of the
 mRNA and by inhibition of protein translation. Recent findings suggest that it may eventually be possible to treat some neurological
 disorders by restoring or inhibiting miRNAs altered by disease pathology. Both viral delivery and administration of modified
 oligonucleotides mimicking or inhibiting specific miRNAs have been effective in model systems. Artificial miRNAs have also
 been generated for t...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811100</comments>
            <pubDate>Thu, 17 Sep 2009 23:13:05 +0100</pubDate>
            <guid isPermaLink="false">2811100</guid>        </item>
        <item>
            <title>Translin-Associated Factor X Gene (TSNAX) may be Associated with Female major Depressive Disorder in the Japanese Population</title>
            <link>http://www.medworm.com/index.php?rid=2811101&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqg6h516644334050%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several investigations have reported that the translin-associated factor X gene (TSNAX)/disrupted-in-schizophrenia-1 gene (DISC1) was associated with major psychiatric disorders including schizophrenia, bipolar disorder (BP), and major depressive disorder
 (MDD). TSNAX is located immediately upstream of DISC1, and has been shown to undergo intergenic splicing with DISC1. It thus may also be influenced by translocation. To our knowledge, there are no reported gene-based association analyses
 between TSNAX and mood disorders in the Japanese population. We conducted a case–control study of Japanese samples (158 bipolar patients,
 314 major depressive disorder patients, and 811 controls) with three tagging SNPs in TSNAX, selected using HapMap database. In addition, we per...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811101</comments>
            <pubDate>Thu, 17 Sep 2009 12:14:16 +0100</pubDate>
            <guid isPermaLink="false">2811101</guid>        </item>
        <item>
            <title>microRNAs in Gliomas: Small Regulators of a Big Problem</title>
            <link>http://www.medworm.com/index.php?rid=2811102&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg6441255462423h4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Gliomas are the most common form of primary brain tumors and are associated with a poor clinical outcome. The molecular mechanisms
 that contribute to gliomagenesis have become increasingly clear in recent years, yet much remains to be learned. This is particularly
 true for the role of microRNAs in gliomagenesis, as an appreciation for the significance of aberrant miRNA expression in human
 cancer has only emerged in the last 5&amp;nbsp;years. It is now evident that microRNAs regulate a wide variety of tumorigenic processes
 including cellular proliferation, differentiation, angiogenesis, invasion, and apoptosis. Here we review the current state
 of knowledge related to the role of microRNAs in glial tumor development. This is a rapidly evolving field and it is likely
 tha...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811102</comments>
            <pubDate>Thu, 17 Sep 2009 12:14:15 +0100</pubDate>
            <guid isPermaLink="false">2811102</guid>        </item>
        <item>
            <title>Dietary Supplementation with S-Adenosyl Methionine Delays the Onset of Motor Neuron Pathology in a Murine Model of Amyotrophic Lateral Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2811103&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw25kr41026752383%2F</link>
            <description>We examined herein whether SAM supplementation could affect the course of motor neuron pathology in mice-expressing mutant
 human SOD-1. SAM delayed disease onset by 2–3&amp;nbsp;weeks. SAM also delayed hallmarks of neurodegeneration in these mice and in
 ALS, including preventing loss of motor neurons, and reducing gliosis, SOD-1 aggregation, protein carbonylation, and induction
 of antioxidant activity. SAM did not increase survival time. These preliminary findings, using a single concentration of SAM,
 suggest that SAM supplementation maybe useful as part of a comprehensive therapeutic approach for ALS.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-009-8089-7Authors
		James Suchy, University of Massachusetts Lowell Center for Cellular Neurobiology and Neurodegen...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811103</comments>
            <pubDate>Wed, 16 Sep 2009 18:45:41 +0100</pubDate>
            <guid isPermaLink="false">2811103</guid>        </item>
        <item>
            <title>Alzheimer’s Disease Amyloid β-Protein and Synaptic Function</title>
            <link>http://www.medworm.com/index.php?rid=2811104&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F52u05v5t0nj8051j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alzheimer’s disease (AD) is characterized neuropathologically by the deposition of different forms of amyloid β-protein (Aβ)
 including variable amounts of soluble species that correlate with severity of dementia. The extent of synaptic loss in the
 brain provides the best morphological correlate of cognitive impairment in clinical AD. Animal research on the pathophysiology
 of AD has therefore focussed on how soluble Aβ disrupts synaptic mechanisms in vulnerable brain regions such as the hippocampus.
 Synapic plasticity in the form of persistent activity-dependent increases or decreases in synaptic strength provide a neurophysiological
 substrate for hippocampal-dependent learning and memory. Acute treatment with human-derived or chemically prepared soluble
 Aβ t...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811104</comments>
            <pubDate>Wed, 16 Sep 2009 18:45:39 +0100</pubDate>
            <guid isPermaLink="false">2811104</guid>        </item>
        <item>
            <title>Are There Common Biochemical and Molecular Mechanisms Controlling Manganism and Parkisonism</title>
            <link>http://www.medworm.com/index.php?rid=2811105&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvmk2g15777422647%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Over the past several decades there has been considerable progress in our basic knowledge as to the mechanisms and factors
 regulating Mn toxicity. The disorder known as manganism is associated with the preferential accumulation of Mn in the globus
 pallidus of the basal ganglia which is generally considered to be the major and initial site of injury. Because the area of
 the CNS comprising the basal ganglia is very complex and dependent on the precise function and balance of several neurotransmitters,
 it is not surprising that symptoms of manganism often overlap with that of Parkinson’s disease. The fact that neurological
 symptoms and onset of Mn toxicity are quite broad and can vary unpredictably probably reflects specific genetic variance of
 the physiological an...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2811105</comments>
            <pubDate>Wed, 16 Sep 2009 18:45:38 +0100</pubDate>
            <guid isPermaLink="false">2811105</guid>        </item>
        <item>
            <title>Macro Role(s) of MicroRNAs in Fragile X Syndrome?</title>
            <link>http://www.medworm.com/index.php?rid=2697688&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw115k32006325077%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Fragile X syndrome (FXS), the most common form of inherited mental retardation, is caused by the loss of functional fragile
 X mental retardation protein (FMRP). FMRP is an RNA-binding protein that can regulate the translation of specific mRNAs. It
 is known to regulate synaptic development through the regulation of local protein synthesis in synapses. MicroRNAs (miRNAs)
 are a class of small noncoding RNAs involved in almost every biological process. They exhibit spatiotemporal expression during
 brain development, and some miRNAs play important roles in neural development. A growing body of evidence now implicates the
 miRNA pathway in the molecular pathogenesis of FXS. Here we review the current state of knowledge about the microRNA pathway
 in neural development and...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697688</comments>
            <pubDate>Tue, 11 Aug 2009 00:10:20 +0100</pubDate>
            <guid isPermaLink="false">2697688</guid>        </item>
        <item>
            <title>Variation in RTN3 and PPIL2 Genes Does not Influence Platelet Membrane β-Secretase Activity or Susceptibility to Alzheimer’s Disease in the Northern Irish Population</title>
            <link>http://www.medworm.com/index.php?rid=2686397&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft768623726656290%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;β-site amyloid precursor protein cleaving enzyme (BACE1) is the rate-limiting enzyme for production of beta-amyloid peptides
 (Aβ), which are proposed to drive the pathological changes found in Alzheimer’s disease (AD). Reticulon 3 (RTN3) is a negative
 modulator of BACE1 (β-secretase) proteolytic activity, while peptidylprolyl isomerase (cyclophilin)-like 2 (PPIL2) positively
 regulates BACE1 expression. The present study investigated whether there was any association between genetic variation in
 RTN3 and PPIL2, and either risk for AD, or levels of platelet β-secretase activity, in a large Northern Irish case-control sample. Four hundred
 and sixty-nine patients with a diagnosis of probable AD (NINCDS-ADRDA criteria) and 347 control individuals (MMSE&amp;nbsp;&amp;gt;&amp;n...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2686397</comments>
            <pubDate>Sun, 09 Aug 2009 07:26:12 +0100</pubDate>
            <guid isPermaLink="false">2686397</guid>        </item>
        <item>
            <title>Interaction Between α-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=2686398&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjr2h2xw124928266%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The most recent literature on the interaction between α-synuclein in its several aggregation states and metal ions is discussed.
 This analysis shows two major types of interactions. Binding sites are present in the C-terminal region, and similar, low
 affinity (in the millimolar range) is exhibited toward many different metal ions, including copper and iron. A more complex
 scenario emerges for these latter metal ions, which are also able to coordinate with high affinity (in the micromolar range)
 to the N-terminal region of α-synuclein. Moreover, these redox-active metal ions may induce chemical modifications on the
 protein in vitro and in the reducing intracellular environment, and these modifications might be relevant for the aggregation
 properties of α-synucle...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2686398</comments>
            <pubDate>Sun, 09 Aug 2009 07:26:11 +0100</pubDate>
            <guid isPermaLink="false">2686398</guid>        </item>
        <item>
            <title>Manganese and its Role in Parkinson’s Disease: From Transport to Neuropathology</title>
            <link>http://www.medworm.com/index.php?rid=2680239&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy3l72687065443v6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The purpose of this review is to highlight recent advances in the neuropathology associated with Mn exposures. We commence
 with a discussion on occupational manganism and clinical aspects of the disorder. This is followed by novel considerations
 on Mn transport (see also chapter by Yokel, this volume), advancing new hypotheses on the involvement of several transporters
 in Mn entry into the brain. This is followed by a brief description of the effects of Mn on neurotransmitter systems that
 are putative modulators of dopamine (DA) biology (the primary target of Mn neurotoxicity), as well as its effects on mitochondrial
 dysfunction and disruption of cellular energy metabolism. Next, we discuss inflammatory activation of glia in neuronal injury
 and how disruption of s...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2680239</comments>
            <pubDate>Wed, 05 Aug 2009 18:43:06 +0100</pubDate>
            <guid isPermaLink="false">2680239</guid>        </item>
        <item>
            <title>Exercise and Bipolar Disorder: A Review of Neurobiological Mediators</title>
            <link>http://www.medworm.com/index.php?rid=2661678&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu8113w2047623575%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Extant evidence indicates that individuals with bipolar disorder (BD) are differentially affected by overweight/obesity and
 abdominal obesity. Excess weight is associated with a more complex illness presentation, non-recovery, and recurrence. Herein,
 we sought to review literature describing the effects of structured individualized physical exercise on disparate neurobiological
 substrates implicated in the pathophysiology of BD. We conducted a PubMed search of all English-language articles published
 between 1966 and July 2008 with BD cross-referenced with the following search terms: exercise, neurobiology, pathophysiology,
 pathoetiology, brain, cognition, neuroplasticity, and neurodegeneration. Articles selected for review were based on adequacy
 of sample size, th...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661678</comments>
            <pubDate>Fri, 31 Jul 2009 18:11:16 +0100</pubDate>
            <guid isPermaLink="false">2661678</guid>        </item>
        <item>
            <title>Interleukin-1 Beta −511C/T Genetic Polymorphism is Associated with Age of Onset of Geriatric Depression</title>
            <link>http://www.medworm.com/index.php?rid=2643136&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv640267v7706620m%2F</link>
            <description>This study tests the hypothesis that a biallelic functional polymorphism in
 the promoter region of the interleukin-1 beta gene (IL1B −511C/T) affects vulnerability to geriatric depression and its manifestations, including age of onset, depression severity,
 and cognitive function. We genotyped the IL1B −511C/T polymorphism in 125 elderly inpatients diagnosed with major depression and 282 normal elderly controls. The depressed
 patients were evaluated at baseline after admission using the Hamilton Rating Scale for Depression (HAM-D) for depression
 severity and the Mini-Mental Status Examination (MMSE) for cognitive function; depression age of onset was evaluated by interview
 and medical records. We found no association between IL1B −511C/T genotypes and geriatric depression suscept...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2643136</comments>
            <pubDate>Sat, 25 Jul 2009 08:52:42 +0100</pubDate>
            <guid isPermaLink="false">2643136</guid>        </item>
        <item>
            <title>MicroRNAs in Adult and Embryonic Neurogenesis</title>
            <link>http://www.medworm.com/index.php?rid=2604121&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F08877147327329g2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurogenesis is defined as a process that includes the proliferation of neural stem/progenitor cells (NPCs) and the differentiation
 of these cells into new neurons that integrate into the existing neuronal circuitry. MicroRNAs (miRNAs) are a recently discovered
 class of small non-protein coding RNA molecules implicated in a wide range of diverse gene regulatory mechanisms. More and
 more data demonstrate that numerous miRNAs are expressed in a spatially and temporally controlled manners in the nervous system,
 which suggests that miRNAs have important roles in the gene regulatory networks involved in both brain development and adult
 neural plasticity. This review summarizes the roles of miRNAs-mediated gene regulation in the nervous system with focus on
 neurogenesis...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2604121</comments>
            <pubDate>Tue, 14 Jul 2009 10:55:38 +0100</pubDate>
            <guid isPermaLink="false">2604121</guid>        </item>
        <item>
            <title>Leukocyte Recruitment and Ischemic Brain Injury</title>
            <link>http://www.medworm.com/index.php?rid=2590072&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnj5876565127k770%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Leukocytes are recruited into the cerebral microcirculation following an ischemic insult. The leukocyte–endothelial cell adhesion
 manifested within a few hours after ischemia (followed by reperfusion, I/R) largely reflects an infiltration of neutrophils,
 while other leukocyte populations appear to dominate the adhesive interactions with the vessel wall at 24&amp;nbsp;h of reperfusion.
 The influx of rolling and adherent leukocytes is accompanied by the recruitment of adherent platelets, which likely enhances
 the cytotoxic potential of the leukocytes to which they are attached. The recruitment of leukocytes and platelets in the postischemic
 brain is mediated by specific adhesion glycoproteins expressed by the activated blood cells and on cerebral microvascular
 endothe...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2590072</comments>
            <pubDate>Mon, 06 Jul 2009 20:04:37 +0100</pubDate>
            <guid isPermaLink="false">2590072</guid>        </item>
        <item>
            <title>Neonatal Estrogenic Effects upon the Male Rat Pituitary: Early Gonadotrophin Attenuation Precedes Long-term Recovery</title>
            <link>http://www.medworm.com/index.php?rid=2565563&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc106mm4422107481%2F</link>
            <description>In this study
 we have investigated the effects of neonatal estrogenic exposure upon the anterior pituitary. Both the early- and late-stage
 effects of exposure to a synthetic estrogenic agent, diethylstilbestrol (DES), upon pituitary gonadotroph cell function were
 assessed. We administered either a high dose (10&amp;nbsp;μg) or a low dose (0.1&amp;nbsp;μg) of DES to male rats during their neonatal period
 (P2–12). Gonadotroph function, cell number and morphology shortly after DES treatment (P18) and during adulthood (P90) were
 assessed. At P18 there was a significant decrease in follicle stimulating hormone (FSH) immunoreactivity in the pituitary
 gonadotroph cells in the high DES dose treated rats compared to control animals. No significant change in luteinizing hormone
 (LH) was observed ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2565563</comments>
            <pubDate>Tue, 30 Jun 2009 15:55:26 +0100</pubDate>
            <guid isPermaLink="false">2565563</guid>        </item>
        <item>
            <title>Amyloid-β Induces a Caspase-mediated Cleavage of P2X4 to Promote Purinotoxicity</title>
            <link>http://www.medworm.com/index.php?rid=2558200&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk8626r53u4v08211%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Overproduction of the β-amyloid fragment 1–42 (Aβ1–42) is thought to contribute to synaptic dysfunction and neuronal death in Alzheimer’s disease. Mounting evidence suggests that
 purinergic receptors play critical roles in synaptic plasticity and neuronal survival, but the potential involvement of these
 receptors in Aβ1–42-induced synaptic dysfunction and neuronal death has not been addressed. Here we report that Aβ1–42 promoted accumulation of the calcium-permeable purinergic receptor P2X4 in neurons. We also report evidence that Aβ1–42 induced a caspase-3-mediated cleavage of the receptor that slowed channel closure times and prevented agonist-induced internalization
 of the receptor. Molecular interference to reduce the expression of P2X4 in primar...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2558200</comments>
            <pubDate>Mon, 29 Jun 2009 08:52:39 +0100</pubDate>
            <guid isPermaLink="false">2558200</guid>        </item>
        <item>
            <title>Epileptic Seizures in AD Patients</title>
            <link>http://www.medworm.com/index.php?rid=2549688&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx08875413k243765%2F</link>
            <description>This article reviews data on the prevalence of seizures in Alzheimer’s disease,
 seizure types, pathophysiology and treatment. Seizure prevalence increases with disease duration, but early-onset disease
 is associated with a greater risk of seizures, in part related to the frequency of presenilin-1 gene mutations in early-onset
 disease. Seizures are mostly of partial origin, with both complex partial and secondary generalised seizures. Seizure pathophysiology
 may relate to increased amyloid beta-peptide production, structural alterations in neurones related to cytoskeletal dysfunction,
 cerebrovascular changes, neurotransmitter dysfunction or combinations thereof. Through modification of these pathophysiological
 pathways, there may be possible roles for anti-epileptic drugs such as so...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2549688</comments>
            <pubDate>Fri, 26 Jun 2009 08:15:46 +0100</pubDate>
            <guid isPermaLink="false">2549688</guid>        </item>
        <item>
            <title>NAD+ Availability and Proteotoxicity</title>
            <link>http://www.medworm.com/index.php?rid=2549689&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv702ru8rxv465550%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It has been shown that NAD+ availability is important for neuronal survival following ischemia (Liu et al., Neuromolecular Med 11:28–42, 2009). It is proposed here that NAD+ may also control proteotoxicity by influencing both formation and catabolism of altered proteins. It is suggested that low
 NAD+ availability promotes synthesis of methylglyoxal (MG) which can induce formation of glycated proteins, ROS, and dysfunctional
 mitochondria. That glyoxalase overexpression and carnosine are both protective against MG and ischemic injury support this
 proposal. Recognition and elimination of altered proteins is enhanced by NAD+ through effects on stress protein expression and autophagy.
 
	Content Type Journal ArticleCategory Review PaperDOI 10.1007/s12017-009-8069-yAutho...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2549689</comments>
            <pubDate>Thu, 25 Jun 2009 07:39:10 +0100</pubDate>
            <guid isPermaLink="false">2549689</guid>        </item>
        <item>
            <title>MicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies</title>
            <link>http://www.medworm.com/index.php?rid=2492039&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc3215723104x4g72%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Psychiatric illnesses are disabling disorders with poorly understood underlying pathophysiologies. However, it is becoming
 increasingly evident that these illnesses result from disruptions across whole cellular networks rather than any particular
 monoamine system. Recent evidence continues to support the hypothesis that these illnesses arise from impairments in cellular
 plasticity cascades, which lead to aberrant information processing in the circuits that regulate mood, cognition, and neurovegetative
 functions (sleep, appetite, energy, etc.). As a result, many have begun to consider future therapies that would be capable
 of affecting global changes in cellular plasticity to restore appropriate synaptic function and neuronal connectivity. MicroRNAs
 (miRNAs) are no...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2492039</comments>
            <pubDate>Sat, 20 Jun 2009 05:50:43 +0100</pubDate>
            <guid isPermaLink="false">2492039</guid>        </item>
        <item>
            <title>Possible Association of Prokineticin 2 Receptor Gene (PROKR2) with Mood Disorders in the Japanese Population</title>
            <link>http://www.medworm.com/index.php?rid=2492038&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl53601j59229n470%2F</link>
            <description>In conclusion, our findings suggest that PROKR2 may play a role in the pathophysiology of mood disorders in the Japanese population. However, because our samples were small,
 it will be important to replicate and confirm these findings in other independent studies using larger samples.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-009-8067-0Authors
		Taro Kishi, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanTsuyoshi Kitajima, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanTomoko Tsunoka, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanTakenori Okumura, Fujita Health University School of Medicine Department of Psychi...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2492038</comments>
            <pubDate>Sat, 20 Jun 2009 05:50:43 +0100</pubDate>
            <guid isPermaLink="false">2492038</guid>        </item>
        <item>
            <title>microRNAs in CNS Disorders</title>
            <link>http://www.medworm.com/index.php?rid=2492040&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc2261p5840001372%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In recent years, there has been a shift in the conventional paradigms for transcriptional and translational regulation as
 extensive sequencing efforts have yielded new insights into the landscape of the human genome and transcriptome. Hundreds
 of non-coding regulatory RNA molecules called microRNAs (miRNAs) have been identified in the mammalian central nervous system
 (CNS) and are reported to mediate pivotal roles in many aspects of neuronal functions. Disruption of miRNA-based post-transcriptional
 regulation has been implicated in a range of CNS disorders as one miRNA is predicted to impact the expression of numerous
 downstream mRNA targets. The intricate molecular networks mediated by an miRNA form a robust mechanism for rapid and potent
 responses to cellular ev...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2492040</comments>
            <pubDate>Thu, 18 Jun 2009 16:04:37 +0100</pubDate>
            <guid isPermaLink="false">2492040</guid>        </item>
        <item>
            <title>A Homozygous Genetic Variant of Mitochondrial Uncoupling Protein 4 Exerts Protection Against the Occurrence of Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=2492041&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4l610882l1023617%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple sclerosis (MS), which results in damage of the white matter at multiple foci, poses a far-reaching public health
 problem in view of the burden it imposes on the affected young and middle-aged. Some previous data suggested that roles could
 be played in the demyelinization of the white matter of the brain by the malfunctioning of the mitochondria and mitochondria-associated
 reactive oxygen species. In this context, we hypothesized that the finely tuned dynamic stability of the mitochondrial membrane
 potential (MMP), which is the main mirror of the functional state of the mitochondria, is essential for the intact nature
 of the glia cells in the brain. Setting out from this, our aim in this study was to examine how the rs10807344 and rs2270450
 genetic variant...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2492041</comments>
            <pubDate>Thu, 18 Jun 2009 16:04:36 +0100</pubDate>
            <guid isPermaLink="false">2492041</guid>        </item>
        <item>
            <title>Matrix Metalloproteinase-9 Gene and Bipolar Mood Disorder</title>
            <link>http://www.medworm.com/index.php?rid=2492042&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu6g181j520322615%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Matrix metalloproteinase-9 (MMP-9) plays a role in many pathological conditions (e.g., cancer and heart disease). Recently,
 MMP-9 has been implicated in various aspects of brain functions (e.g., neuroplasticity and epileptogenesis) and thus, we hypothesized
 that MMP-9 gene may be associated with bipolar mood disorder. The study was performed on 416 patients with bipolar mood disorder, including
 75 patients with bipolar II type of the illness, and in 558 healthy control persons. A functional −1562C/T polymorphism of
 the MMP-9 gene was genotyped in all subjects. Patients with bipolar mood disorder had significant preponderance of T allele versus
 C allele of 1562C/T polymorphism of the MMP-9 gene, compared to healthy control subjects. The higher frequency of T allel...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2492042</comments>
            <pubDate>Thu, 18 Jun 2009 16:04:34 +0100</pubDate>
            <guid isPermaLink="false">2492042</guid>        </item>
        <item>
            <title>No Association Between Polymorphisms of Neuronal Oxide Synthase 1 Gene (NOS1) and Schizophrenia in a Japanese Population</title>
            <link>http://www.medworm.com/index.php?rid=2480464&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F665315203h107828%2F</link>
            <description>In conclusion, we could not replicate the association between seven SNPs in NOS1 and schizophrenia found in several earlier studies, using larger Japanese schizophrenia and control samples.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-009-8068-zAuthors
		Takenori Okumura, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanTomo Okochi, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanTaro Kishi, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanMasashi Ikeda, Fujita Health University School of Medicine Department of Psychiatry Toyoake Aichi 470-1192 JapanTsuyoshi Kitajima, Fujita Health University School of Medicine Departme...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2480464</comments>
            <pubDate>Wed, 10 Jun 2009 11:37:08 +0100</pubDate>
            <guid isPermaLink="false">2480464</guid>        </item>
        <item>
            <title>Gene Dysregulation in Huntington’s Disease: REST, MicroRNAs and Beyond</title>
            <link>http://www.medworm.com/index.php?rid=2429964&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0ur435655261w071%2F</link>
            <description>In this study we will discuss these findings and their implications for our understanding of HD. Using
 updated bioinformatic analysis, we predict 21 new candidate microRNAs in HD. We propose future strategies for unifying large-scale
 transcriptional and microRNA datasets with the aim of explaining HD aetiology. By way of example, we show how available genomic
 datasets can be integrated to provide independent, analytical validation for dysregulation of REST and microRNA mir-124 in
 HD. As a consequence, gene ontology analysis indicates that HD is characterised by a broad-based depression of neural genes
 in the caudate and motor cortex. Thus, we propose that a combination of REST, microRNAs and possibly other non-coding RNAs
 profoundly affect the neuronal transcriptome in HD.
 
	Content...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2429964</comments>
            <pubDate>Thu, 21 May 2009 06:01:19 +0100</pubDate>
            <guid isPermaLink="false">2429964</guid>        </item>
        <item>
            <title>microRNA Regulation of Synaptic Plasticity</title>
            <link>http://www.medworm.com/index.php?rid=2429965&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp464w60470520v38%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;microRNAs play an important role in regulating synaptic plasticity. For example, microRNAs target (and are targeted by) plasticity
 mediators such as CREB, MECP2, and FMRP. As well, specific microRNAs have been shown to be expressed within dendrites, where
 they regulate protein translation of targets mediating dendritic growth. Components of the RISC machinery have been implicated
 in long-term memory in Drosophila. Here, we review evidence from studies of adult mouse forebrain supporting a model wherein synaptic stimulation (above a
 threshold value) increases calcium within dendritic spines, activates calpain, and activates and releases dicer from the postsynaptic
 density. Dicer processes local pre-miRs into mature miRNAs that are incorporated into RISC complexes wi...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2429965</comments>
            <pubDate>Thu, 21 May 2009 06:01:18 +0100</pubDate>
            <guid isPermaLink="false">2429965</guid>        </item>
        <item>
            <title>Decline in Daily Running Distance Presages Disease Onset in a Mouse Model of ALS</title>
            <link>http://www.medworm.com/index.php?rid=2400795&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy745843h11w71873%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of lower motor neurons resulting in paralysis
 and death. Epidemiological and clinical findings suggest that a decline in athletic performance may presage the clinical onset
 of ALS, but this possibility has not been tested in an animal model. By placing running wheels in each mouse’s cage to measure
 their exercise activity, we show that presymptomatic G93A SOD1 ALS mice are more active runners (15–20&amp;nbsp;km/day) than control
 mice (7–9&amp;nbsp;km/day). The ALS mice then exhibit a sharp decline in daily running distance 10–20&amp;nbsp;days prior to the onset of clinical
 disease. Within the group of ALS mice, there were no significant correlations between cumulative lifetime running dist...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2400795</comments>
            <pubDate>Wed, 06 May 2009 06:02:38 +0100</pubDate>
            <guid isPermaLink="false">2400795</guid>        </item>
        <item>
            <title>Novel GDAP1 Mutation in a Turkish Family with CMT2K (CMT2K with Novel GDAP1 Mutation)</title>
            <link>http://www.medworm.com/index.php?rid=2357908&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2r150r0554947614%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause Charcot–Marie–Tooth type 2 (CMT2), a severe autosomal recessive form of neuropathy associated with axonal phenotypes.
 It has been screened in this study for the presence of mutations in the coding region of GDAP1, which maps to chromosome 8q21, in a family with CMT2. To date, 29 mutations in the GDAP1 have been reported in patients of different ethnic origins. Here, we report a novel missense mutation (c.836A&amp;gt;G), and two
 polymorphisms: a silent variant (c.102G&amp;gt;C), and a 5′-splice site mutation (IVS5+24C&amp;gt;T) in GDPA1 gene identified in a five generation Turkish family with autosomal recessive CMT2.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2357908</comments>
            <pubDate>Tue, 21 Apr 2009 10:49:16 +0100</pubDate>
            <guid isPermaLink="false">2357908</guid>        </item>
        <item>
            <title>Induction of Early Growth Response-1 Mediates Microglia Activation In Vitro But is Dispensable In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=2335131&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy3t2132481622711%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We have previously identified activation of microglia and induction of the early growth response gene 1 (Egr1) in the retina
 of retinoschisin-deficient (Rs1h−/Y) mice. We hypothesized that microglial expression of Egr1 might support retinal microgliosis. To test this, Egr1 transcript
 levels were determined in RNAs isolated from early postnatal retinas and primary microglia from Rs1h−/Y mice and wild-type controls. Egr1 mRNA expression was strongly induced in retinoschisin-deficient retinas as well as in ex
 vivo isolated microglia. Increased microglial Egr1 protein expression was concordantly detected in retinal sections of Rs1h−/Y mice using immunohistochemistry. Prominent activation-dependent Egr1 mRNA and protein expression was also confirmed in murine
 BV-2 ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2335131</comments>
            <pubDate>Tue, 14 Apr 2009 06:13:57 +0100</pubDate>
            <guid isPermaLink="false">2335131</guid>        </item>
        <item>
            <title>CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients</title>
            <link>http://www.medworm.com/index.php?rid=2574681&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1j2825736w4737p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent studies have shown that selective serotonin reuptake inhibitors (SSRIs) have circadian properties, suggesting that
 the antidepressive action of SSRIs may also be attributable to circadian mechanisms. Another study reported an association
 between clock gene (CLOCK) and improvements in insomnia symptoms from SSRIs treatment. Therefore, we examined the association between CLOCK and the efficacy of fluvoxamine treatment in 121 patients with Japanese major depressive disorder (MDD). The MDD patients
 in this study had scores of 12 or higher on the 17 items of the Structured Interview Guide for Hamilton Rating Scale for Depression
 (SIGH-D). We defined a therapeutic response as a decrease of more than a 50% in baseline SIGH-D within 8&amp;nbsp;weeks, and clinical
 remiss...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574681</comments>
            <pubDate>Sun, 05 Apr 2009 13:09:59 +0100</pubDate>
            <guid isPermaLink="false">2574681</guid>        </item>
        <item>
            <title>CLOCK
 may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients</title>
            <link>http://www.medworm.com/index.php?rid=2311045&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1j2825736w4737p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent studies have shown that selective serotonin reuptake inhibitors (SSRIs) have circadian properties, suggesting that
 the antidepressive action of SSRIs may also be attributable to circadian mechanisms. Another study reported an association
 between clock gene (CLOCK) and improvements in insomnia symptoms from SSRIs treatment. Therefore, we examined the association between CLOCK and the efficacy of fluvoxamine treatment in 121 patients with Japanese major depressive disorder (MDD). The MDD patients
 in this study had scores of 12 or higher on the 17 items of the Structured Interview Guide for Hamilton Rating Scale for Depression
 (SIGH-D). We defined a therapeutic response as a decrease of more than a 50% in baseline SIGH-D within 8&amp;nbsp;weeks, and clinical
 remiss...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2311045</comments>
            <pubDate>Sun, 05 Apr 2009 13:09:59 +0100</pubDate>
            <guid isPermaLink="false">2311045</guid>        </item>
        <item>
            <title>AAV-mediated Local Delivery of Interferon-β for the Treatment of Retinoblastoma in Preclinical Models</title>
            <link>http://www.medworm.com/index.php?rid=2289552&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh4222615415107rr%2F</link>
            <description>In this study, we tested the efficacy of AAV-mediated local
 delivery of IFN-β for the treatment of retinoblastoma in preclinical models. Retinoblastoma is an ideal candidate for gene-therapy-based
 anti-cancer treatment because target cell transduction and, therefore, IFN-β delivery can be contained within the ocular environment,
 thereby minimizing systemic toxicity. We report here that retinoblastoma cell lines exhibit pleiotropic responses to IFN-β
 consistent with previous studies on a variety of tumor cell lines. Intravitreal injection of AAV-IFN-β resulted in efficient
 retinal infection and sustained IFN-β production in the eye with minimal systemic exposure. Vector spread outside of the eye
 was not detected. Using our orthotopic xenograft model of retinoblastoma, we found th...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2289552</comments>
            <pubDate>Sun, 22 Mar 2009 06:08:10 +0100</pubDate>
            <guid isPermaLink="false">2289552</guid>        </item>
        <item>
            <title>Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons</title>
            <link>http://www.medworm.com/index.php?rid=2278686&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0625895647j41t82%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurons require large amounts of energy to support their survival and function, and are therefore susceptible to excitotoxicity,
 a form of cell death involving bioenergetic stress that may occur in several neurological disorders including stroke and Alzheimer’s
 disease. Here we studied the roles of NAD+ bioenergetic state, and the NAD+-dependent enzymes SIRT1 and PARP-1, in excitotoxic neuronal death in cultured neurons and in a mouse model of focal ischemic
 stroke. Excitotoxic activation of NMDA receptors induced a rapid decrease of cellular NAD(P)H levels and mitochondrial membrane
 potential. Decreased NAD+ levels and poly (ADP-ribose) polymer (PAR) accumulation in nuclei were relatively early events (&amp;lt;4&amp;nbsp;h) that preceded the appearance
 of propidium iodi...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2278686</comments>
            <pubDate>Sat, 14 Mar 2009 14:43:16 +0100</pubDate>
            <guid isPermaLink="false">2278686</guid>        </item>
        <item>
            <title>Botanical Phenolics and Brain Health</title>
            <link>http://www.medworm.com/index.php?rid=2163936&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2311jvl0307h3142%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The high demand for molecular oxygen, the enrichment of polyunsaturated fatty acids in membrane phospholipids, and the relatively
 low abundance of antioxidant defense enzymes are factors rendering cells in the central nervous system (CNS) particularly
 vulnerable to oxidative stress. Excess production of reactive oxygen species (ROS) in the brain has been implicated as a common
 underlying factor for the etiology of a number of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s
 disease (PD), and stroke. While ROS are generated by enzymatic and nonenzymatic reactions in the mitochondria and cytoplasm
 under normal conditions, excessive production under pathological conditions is associated with activation of Ca2+-dependent enzymes including...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2163936</comments>
            <pubDate>Wed, 04 Feb 2009 14:02:29 +0100</pubDate>
            <guid isPermaLink="false">2163936</guid>        </item>
        <item>
            <title>Voltammetric Bioassay of Caffeine using Sensor Implant</title>
            <link>http://www.medworm.com/index.php?rid=2075145&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F408587p320887428%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In this article, we examined the performance of the voltammetric assay of caffeine using DNA immobilized onto a carbon nanotube
 paste electrode (DPE) and compared it with that of an ordinary carbon nanotube paste electrode (PE). Under optimal conditions,
 the working ranges for caffeine were from 0.1 to 12&amp;nbsp;mg&amp;nbsp;l−1 (for DPE) and 30–230&amp;nbsp;mg&amp;nbsp;l−1 (for PE). Detection limits (DLs) of 0.068&amp;nbsp;mg&amp;nbsp;l−1 (3.50&amp;nbsp;×&amp;nbsp;10−7&amp;nbsp;M) DPE and 9.94&amp;nbsp;mg&amp;nbsp;l−1 (5.12×10−5&amp;nbsp;M) PE were obtained and the relative standard deviation at the caffeine concentration of 5.0&amp;nbsp;mg&amp;nbsp;l−1 was 0.064% (n&amp;nbsp;=&amp;nbsp;15) DPE under optimum conditions. The sensor could be implanted in a leaf skin or animal brain cell, which can then be interfa...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2075145</comments>
            <pubDate>Thu, 01 Jan 2009 06:48:32 +0100</pubDate>
            <guid isPermaLink="false">2075145</guid>        </item>
        <item>
            <title>Common Variations in 4p Locus are Related to Male Completed Suicide</title>
            <link>http://www.medworm.com/index.php?rid=2075146&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl782vt5w26055164%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Suicidal behavior is a multifactorial phenomenon, with a significant genetic predisposition. To assess the contribution of
 genes in the 4p region to suicide risk, we genotyped 36 single nucleotide polymorphisms from a 49Mb region on the chromosome
 arm 4p11-16 in a total of 288 male suicide victims and 327 healthy male volunteers. The nonsynonymous variants rs1383180 in
 EVC gene, rs6811863 in TBC1D1 gene, rs362272 in HTT gene, and rs734312 in WFS1 gene were associated to the male completed suicide. However, only EVC polymorphism remained significant after correcting for multiple comparisons (P&amp;nbsp;&amp;lt;&amp;nbsp;.05 after 10&amp;nbsp;K permutations). The function of these genes is not clear yet. WFS1 and HTT are related to the unfolded protein
 response and endoplasmic reticu...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2075146</comments>
            <pubDate>Tue, 30 Dec 2008 07:34:50 +0100</pubDate>
            <guid isPermaLink="false">2075146</guid>        </item>
        <item>
            <title>Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases</title>
            <link>http://www.medworm.com/index.php?rid=1961372&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8uj71v5347588352%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Substantial evidence indicates bioenergetic dysfunction and mitochondrial impairment contribute either directly and/or indirectly
 to the pathogenesis of numerous neurodegenerative disorders. Treatment paradigms aimed at ameliorating this cellular energy
 deficit and/or improving mitochondrial function in these neurodegenerative disorders may prove to be useful as a therapeutic
 intervention. Creatine is a molecule that is produced both endogenously, and acquired exogenously through diet, and is an
 extremely important molecule that participates in buffering intracellular energy stores. Once creatine is transported into
 cells, creatine kinase catalyzes the reversible transphosphorylation of creatine via ATP to enhance the phosphocreatine energy
 pool. Creatine kinase e...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1961372</comments>
            <pubDate>Thu, 13 Nov 2008 15:56:03 +0100</pubDate>
            <guid isPermaLink="false">1961372</guid>        </item>
        <item>
            <title>Human BDNF Isoforms are Differentially Expressed in Cocaine Addicts and are Sorted to the Regulated Secretory Pathway Independent of the Met66 Substitution</title>
            <link>http://www.medworm.com/index.php?rid=1906245&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgvm73g3810117316%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Differential BDNF gene (BDNF) promoter use leads to protein isoforms differing by 8 or 15 N-terminal residues (BDNF1 and BDNF2) whose regulation and function
 are not completely understood versus the well-known 247-aa BDNF “short” form. To describe how BDNF isoform levels were regulated by chronic drug use, we measured BDNF isoform-specific mRNA levels in different human brain regions from cocaine addicts relative to age, race, and gender-matched
 controls. The cocaine group had threefold higher levels of exon 4-specific (BDNF Short) mRNAs in cerebellum versus controls
 (P&amp;nbsp;&amp;lt;&amp;nbsp;0.01). In cortex, exon 4 and exon 1-specific BDNF mRNA levels (BDNF1) were significantly reduced in the cocaine group relative to controls (40%, P&amp;nbsp;&amp;lt;&amp;nbsp;0.01). We also test...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1906245</comments>
            <pubDate>Thu, 23 Oct 2008 06:03:02 +0100</pubDate>
            <guid isPermaLink="false">1906245</guid>        </item>
        <item>
            <title>Coupling Endoplasmic Reticulum Stress to the Cell Death Program in Dopaminergic Cells: Effect of Paraquat</title>
            <link>http://www.medworm.com/index.php?rid=1775773&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj748x2616410r74g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD) features oxidative stress and accumulation of misfolded (unfolded, alternatively folded, or mutant)
 proteins with associated loss of dopaminergic neurons. Oxidative stress and the accumulated misfolded proteins elicit cellular
 responses that include an endoplasmic reticulum (ER) stress response that may protect cells against the toxic buildup of misfolded
 proteins. Chronic ER stress and accumulation of misfolded proteins in excessive amounts, however, overwhelm the cellular ‘quality
 control’ system and impair the protective mechanisms designed to promote correct folding and degrade faulty proteins, ultimately
 leading to organelle dysfunction and neuronal cell death. Paraquat belongs to a class of bipyridyl herbicides and triggers
 oxi...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1775773</comments>
            <pubDate>Fri, 05 Sep 2008 17:31:31 +0100</pubDate>
            <guid isPermaLink="false">1775773</guid>        </item>
        <item>
            <title>Mutual Stimulation of Beta-Amyloid Fibrillogenesis by Clioquinol and Divalent Metals</title>
            <link>http://www.medworm.com/index.php?rid=1750466&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp33l8638304k8070%2F</link>
            <description>Content Type Journal ArticleCategory ErratumDOI 10.1007/s12017-008-8050-1Authors
		Silvia Bolognin, University of Padova Department of Biology, Padova ‘‘Metalloproteins’’ Unit, CNR-Institute of Biomedical Technologies Via Ugo Bassi 58B 35121 Padova ItalyPaolo Zatta, University of Padova Department of Biology, Padova ‘‘Metalloproteins’’ Unit, CNR-Institute of Biomedical Technologies Via Ugo Bassi 58B 35121 Padova ItalyDenise Drago, University of Padova Department of Biology, Padova ‘‘Metalloproteins’’ Unit, CNR-Institute of Biomedical Technologies Via Ugo Bassi 58B 35121 Padova ItalyGiuseppe Tognon, University of Padova Department of Biology, Padova ‘‘Metalloproteins’’ Unit, CNR-Institute of Biomedical Technologies Via Ugo Bassi 58B 35121 Padova ItalyPier P...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1750466</comments>
            <pubDate>Sat, 30 Aug 2008 17:21:58 +0100</pubDate>
            <guid isPermaLink="false">1750466</guid>        </item>
        <item>
            <title>Evaled Expression of ICAM-1 and Its Ligands in the Rat Spinal Cord Following Lipopolysaccharide Intraspinal Injection</title>
            <link>http://www.medworm.com/index.php?rid=1750467&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff2t361l621091327%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The early stage of inflammation involves the adhesion and transmigration of leukocytes across the blood–brain barrier (BBB)
 to the normally sequestered central nervous system (CNS). This process is regulated by the expression of a series of adhesion
 molecules. One of the most well-known components is intercellular adhesion molecule-1 (ICAM-1). It was described as a ligand
 of the membrane-bound integrin receptors lymphocyte function-associated antigen-1 (LFA-1) and monocyte adhesion molecules-1
 (Mac-1) on leukocytes, and was involved in the adhesion and transmigration of leukocytes. Studies have demonstrated the upregulation
 of ICAM-1 in many tissues after lipopolysaccharide (LPS) stimulation, for example. In the CNS, recent studies just focus on
 the relatively a...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1750467</comments>
            <pubDate>Sat, 30 Aug 2008 17:21:56 +0100</pubDate>
            <guid isPermaLink="false">1750467</guid>        </item>
        <item>
            <title>Mutual Stimulation of Beta-Amyloid Fibrillogenesis by Clioquinol and Divalent Metals</title>
            <link>http://www.medworm.com/index.php?rid=1723740&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa85460k343v05200%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As reported by some authors, clioquinol (CQ), a 8-hydroxyquinoline derivative, has produced very encouraging results in the
 treatment of Alzheimer’s disease (AD). Its biological effects are most likely ascribed to complexation of specific metal ions,
 such as copper (II) and zinc (II), critically associated with β-amyloid (Aβ) aggregation/fibrillogenesis and degeneration
 processes in the brain. The present study was aimed at assessing the in&amp;nbsp;vitro effects of CQ on the aggregation/fibrillogenesis
 properties of human Aβ either alone or complexed with Cu2+ and Zn2+. Surprisingly, our data indicated that CQ promoted rather than inhibited the formation of Aβ fibrillar aggregates when added
 metal ions were present. To understand whether the latter effects were ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1723740</comments>
            <pubDate>Tue, 19 Aug 2008 23:05:38 +0100</pubDate>
            <guid isPermaLink="false">1723740</guid>        </item>
        <item>
            <title>Genetic Variation in the α7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=1705036&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8555mh6500772w36%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Psychotic symptoms are common in Alzheimer’s disease (AD) and have a negative impact on quality of life. It is suggested that
 psychotic symptoms may be attributed to genetic risk factors which are revealed during neurodegeneration. CHRNA7, the gene
 for the α7 nicotinic acetylcholine receptor, has been associated with schizophrenia in linkage and association studies. Hence
 we investigated single SNPs and haplotypes in CHRNA7 in relation to AD with psychosis in a large, well-characterised and previously
 described cohort within the Northern Ireland population. A significant association between delusions and the T allele of rs6494223
 (P&amp;nbsp;=&amp;nbsp;0.014, OR&amp;nbsp;=&amp;nbsp;1.63, CI&amp;nbsp;=&amp;nbsp;1.22–2.17) was found. This suggests that the α7 receptor may be a suitabl...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1705036</comments>
            <pubDate>Tue, 12 Aug 2008 07:23:20 +0100</pubDate>
            <guid isPermaLink="false">1705036</guid>        </item>
        <item>
            <title>BACE1
 Polymorphisms Do Not Influence Platelet Membrane β-secretase Activity or Genetic Susceptibility for Alzheimer’s Disease in the Northern Irish Population</title>
            <link>http://www.medworm.com/index.php?rid=1552016&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe0541424851423rp%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) is a biological and positional candidate gene for Alzheimer’s disease (AD). BACE1 is a protease that catalyses APP cleavage
 at the β-secretase site. We evaluated all common and putatively functional polymorphisms in the genomic region encompassing
 BACE1 for an association with AD, and for functional effects on platelet β-secretase activity. Tag SNPs (n&amp;nbsp;=&amp;nbsp;10) derived from phase II of the International HapMap Project, and a nonsynonymous variant, were successfully genotyped
 in 901 Caucasian individuals from Northern Ireland using Sequenom iPLEX and TaqMan technologies. APOE genotyping was performed by PCR-RFLP. Platelet membrane β-secretase activity was assayed in a subset of individuals (...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1552016</comments>
            <pubDate>Thu, 26 Jun 2008 06:15:30 +0100</pubDate>
            <guid isPermaLink="false">1552016</guid>        </item>
        <item>
            <title>Mitochondrial Medicine for Aging and Neurodegenerative Diseases</title>
            <link>http://www.medworm.com/index.php?rid=1535965&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8r1310q48u375037%2F</link>
            <description>This article discusses critical issues of mitochondria causing dysfunction in aging and neurodegenerative
 diseases, and discusses the potential of developing mitochondrial medicine, particularly mitochondrially targeted antioxidants,
 to treat aging and neurodegenerative diseases.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-008-8044-zAuthors
		P. Hemachandra Reddy, Oregon Health &amp; Science University Neurogenetics Laboratory, Neurological Sciences Institute 505 NW 185th Avenue Beaverton OR 97006 USA
	

	
		Journal NeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084 (Source: NeuroMolecular Medicine)</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1535965</comments>
            <pubDate>Fri, 20 Jun 2008 05:51:03 +0100</pubDate>
            <guid isPermaLink="false">1535965</guid>        </item>
        <item>
            <title>Association Study of Theta EEG Asymmetry and Brain-derived Neurotrophic Factor Gene Variants in Childhood-onset Mood Disorder</title>
            <link>http://www.medworm.com/index.php?rid=1509242&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq534h2gqk72k2260%2F</link>
            <description>Conclusions Our results suggest that the functional Val66Met polymorphism affects theta EEG asymmetry in parietal brain regions specifically
 in individuals with COMD.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-008-8038-xAuthors
		Natalie L. Bulgin, University of Toronto Centre for Addiction and Mental Health 250 College St. Toronto ON Canada M5T 1R8John S. Strauss, University of Toronto Centre for Addiction and Mental Health 250 College St. Toronto ON Canada M5T 1R8Nicole A. King, University of Toronto Centre for Addiction and Mental Health 250 College St. Toronto ON Canada M5T 1R8Sajid A. Shaikh, University of Toronto Centre for Addiction and Mental Health 250 College St. Toronto ON Canada M5T 1R8Charles J. George, University of Pittsburgh Medical Center Wes...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509242</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:55 +0100</pubDate>
            <guid isPermaLink="false">1509242</guid>        </item>
        <item>
            <title>Neurological Benefits of Omega-3 Fatty Acids</title>
            <link>http://www.medworm.com/index.php?rid=1509241&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1862131482676824%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The central nervous system is highly enriched in long-chain polyunsaturated fatty acid (PUFA) of the omega-6 and omega-3 series.
 The presence of these fatty acids as structural components of neuronal membranes influences cellular function both directly,
 through effects on membrane properties, and also by acting as a precursor pool for lipid-derived messengers. An adequate intake
 of omega-3 PUFA is essential for optimal visual function and neural development. Furthermore, there is increasing evidence
 that increased intake of the long-chain omega-3 PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may confer
 benefits in a variety of psychiatric and neurological disorders, and in particular neurodegenerative conditions. However,
 the mechanisms underly...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509241</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:55 +0100</pubDate>
            <guid isPermaLink="false">1509241</guid>        </item>
        <item>
            <title>Impact of Energy Intake and Expenditure on Neuronal Plasticity</title>
            <link>http://www.medworm.com/index.php?rid=1509243&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgk0v530683j85648%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Roman poet Horace was among the first to recognize that when “clogged with yesterday’s excess, the body drags the mind
 down with it.” Although considerable attention has been paid in neuroscience to the enhancement of neuronal function by wheel
 running and caloric restriction, far less is known about the other side of this issue. What are the consequences of unhealthy
 habits to central nervous system function? Prolonged exposure to excessive caloric intake impairs neuronal function and also
 contributes to obesity and other risk factors for diabetes. Diabetes, a disease characterized by reduced sensitivity to glucose
 and insulin, is also associated with deficits in brain structure and function. In contrast, enhancement of somatic metabolism
 by wheel runni...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509243</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:54 +0100</pubDate>
            <guid isPermaLink="false">1509243</guid>        </item>
        <item>
            <title>Functional Polymorphism of the Human Multidrug Resistance Gene (
 MDR1
 ) and Polydipsia–Hyponatremia in Schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=1509244&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8021671057017581%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;P-glycoprotein (P-gp), which is coded by the MDR1 gene, in the brain capillary endothelial cell limits the entry of many drugs including antipsychotics into the brain. The
 aim of this study is to examine whether a functional polymorphism, a C to T substitution at position 3435 in exon 26 of the
 MDR1 gene, is associated with susceptibility to polydipsia–hyponatremia in schizophrenia (SCZ) in a Japanese case–control sample.
 It has been reported that individuals homozygous for this polymorphism had significantly lower MDR1 expression levels and dysfunction of MDR1 (PNAS 97:3473–3478, 2000). Furthermore, the brain entry of risperidone and 9-hydroxyrisperidone has been shown to be greatly
 limited by P-gp (Int J Neuropsychopharmacol 7:415–419, 2004). In order to o...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509244</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:53 +0100</pubDate>
            <guid isPermaLink="false">1509244</guid>        </item>
        <item>
            <title>Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=1509246&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy5458178834j015m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyloid plaques are composed primarily of amyloid-beta (Aβ) peptides derived from proteolytic cleavage of amyloid precursor
 protein (APP) and are considered to play a pivotal role in Alzheimer’s disease (AD) pathogenesis. Presently, AD is diagnosed
 after the onset of clinical manifestations. With the arrival of novel therapeutic agents for treatment of AD, there is an
 urgent need for biomarkers to detect early stages of AD. Measurement of plasma Aβ has been suggested as an inexpensive and
 non-invasive tool to diagnose AD and to monitor Aβ modifying therapies. However, the majority of cross-sectional studies on
 plasma Aβ levels in humans have not shown differences between individuals with AD compared to controls. Similarly, cross-sectional
 studies of mouse pl...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509246</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:52 +0100</pubDate>
            <guid isPermaLink="false">1509246</guid>        </item>
        <item>
            <title>Hormetic Dietary Phytochemicals</title>
            <link>http://www.medworm.com/index.php?rid=1509245&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0234784862203488%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Compelling evidence from epidemiological studies suggests beneficial roles of dietary phytochemicals in protecting against
 chronic disorders such as cancer, and inflammatory and cardiovascular diseases. Emerging findings suggest that several dietary
 phytochemicals also benefit the nervous system and, when consumed regularly, may reduce the risk of disorders such as Alzheimer’s
 and Parkinson’s diseases. The evidence supporting health benefits of vegetables and fruits provide a rationale for identification
 of the specific phytochemicals responsible, and for investigation of their molecular and cellular mechanisms of action. One
 general mechanism of action of phytochemicals that is emerging from recent studies is that they activate adaptive cellular
 stress respon...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509245</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:52 +0100</pubDate>
            <guid isPermaLink="false">1509245</guid>        </item>
        <item>
            <title>The Nonsynonymous Thr105Ile Polymorphism of the Histamine 
 N
 -Methyltransferase is Associated to the Risk of Developing Essential Tremor</title>
            <link>http://www.medworm.com/index.php?rid=1509247&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp2m2717301m33721%2F</link>
            <description>Conclusion These results, combined with previous findings indicating alterations in the frequency for the HNMT Thr105Ile polymorphism in patients with PD, suggest that alterations of histamine homeostasis in the SNC are associated with
 the risk of movement disorders.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-008-8040-3Authors
		Maria C. Ledesma, Medical School, University of Extremadura Department of Pharmacology &amp; Psychiatry Badajoz SpainElena García-Martín, School of Biological Sciences, University of Extremadura Department of Biochemistry and Molecular Biology Avda. de Elvas s/n 06071 Badajoz SpainHortensia Alonso-Navarro, Príncipe de Asturias Hospital, University of Alcalá de Henares Department of Medicine-Neurology Madrid SpainCarmen Martínez, Medi...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1509247</comments>
            <pubDate>Tue, 10 Jun 2008 05:49:50 +0100</pubDate>
            <guid isPermaLink="false">1509247</guid>        </item>
        <item>
            <title>Exercising Our Brains: How Physical Activity Impacts Synaptic Plasticity in the Dentate Gyrus</title>
            <link>http://www.medworm.com/index.php?rid=1500404&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flp1159671050744x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exercise that engages the cardiovascular system has a myriad of effects on the body; however, we usually do not give much
 consideration to the benefits it may have for our minds. An increasing body of evidence suggests that exercise can have some
 remarkable effects on the brain. In this article, we will introduce how exercise can impact the capacity for neurons in the
 brain to communicate with one another. To properly convey this information, we will first briefly introduce the field of synaptic
 plasticity and then examine how the introduction of exercise to the experimental setting can actually alter the basic properties
 of synaptic plasticity in the brain. Next, we will examine some of the candidate physiological processes that might underlay
 these alterations. ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1500404</comments>
            <pubDate>Fri, 06 Jun 2008 05:53:07 +0100</pubDate>
            <guid isPermaLink="false">1500404</guid>        </item>
        <item>
            <title>Integrin β4 in Neural Cells</title>
            <link>http://www.medworm.com/index.php?rid=1488830&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F967gng0774084623%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Integrin β4, one of the heterodimeric receptors, is expressed predominantly on epithelial cells. It is concentrated at the
 basement membrane zone, where it localizes to specialized adhesion structures called hemidesmosomes. In addition to its adhesive
 functions, novel insights have emerged regarding the specific roles of integrin β4 in their attachment to extracellular matrix
 and in their signal transduction pathways within the central nervous system (CNS) and peripheral nervous system in the past
 few years. It has been reported that integrin β4 is expressed in several kinds of neural cells including astrocyte, Schwann
 cells, neurons, and neural stem cells. In the mean while, it is expressed by some Schwann cells in the peripheral nervous
 system and mediated th...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1488830</comments>
            <pubDate>Sat, 31 May 2008 06:52:51 +0100</pubDate>
            <guid isPermaLink="false">1488830</guid>        </item>
        <item>
            <title>Dietary Amino Acids and Brain Serotonin Function; Implications for Stress-Related Affective Changes</title>
            <link>http://www.medworm.com/index.php?rid=1488829&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh373q56730m1427l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Stress-related mood deterioration and affective disorders, such as depression, are among the leading causes of disease burden
 throughout the world, and are associated with severe medical consequences and mortality. Research has shown the involvement
 of dysfunctional brain serotonin (5-HT) biochemistry as a vulnerable biological factor in the onset of mood disturbances.
 Since the production of brain serotonin is limited by the availability of its plasma dietary amino acid precursor tryptophan,
 different foods and dietary amino acids that influence tryptophan availability are thought to alter affective behavior by
 changing brain 5-HT synthesis. Most dietary manipulation studies, however, reveal only modest affective changes, and note
 that these particularly occur in...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1488829</comments>
            <pubDate>Sat, 31 May 2008 06:52:51 +0100</pubDate>
            <guid isPermaLink="false">1488829</guid>        </item>
        <item>
            <title>Autonomic Control of the Aging Heart</title>
            <link>http://www.medworm.com/index.php?rid=1303518&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjg58j24124uw4718%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cardiovascular diseases including hypertension, myocardial infarction, stroke, and heart failure continue to account for the
 majority of deaths in the developed world. Whilst the incidence of these clinical disorders does increase with age, outcomes
 in affected patients tend to be disproportionately adverse with advancing years. In this context it is important to understand
 the various compensatory processes which become activated in cardiovascular disease. In particular, the autonomic nervous
 system is known to play a key pathogenic role in the cause and response to many of these conditions. The normal aging process
 is accompanied by a complex series of changes in the autonomic control of the cardiovascular system, favoring heightened cardiac
 sympathetic tone wit...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1303518</comments>
            <pubDate>Thu, 13 Mar 2008 07:01:17 +0100</pubDate>
            <guid isPermaLink="false">1303518</guid>        </item>
        <item>
            <title>Exercise, Learned Helplessness, and the Stress-Resistant Brain</title>
            <link>http://www.medworm.com/index.php?rid=1261871&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd71p3266786g7275%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Exercise can prevent the development of stress-related mood disorders, such as depression and anxiety. The underlying neurobiological
 mechanisms of this effect, however, remain unknown. Recently, researchers have used animal models to begin to elucidate the
 potential mechanisms underlying the protective effects of physical activity. Using the behavioral consequences of uncontrollable
 stress or “learned helplessness” as an animal analog of depression- and anxiety-like behaviors in rats, we are investigating
 factors that could be important for the antidepressant and anxiolytic properties of exercise (i.e., wheel running). The current
 review focuses on the following: (1) the effect of exercise on the behavioral consequences of uncontrollable stress and the
 implic...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1261871</comments>
            <pubDate>Tue, 26 Feb 2008 15:33:42 +0100</pubDate>
            <guid isPermaLink="false">1261871</guid>        </item>
        <item>
            <title>Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1250531&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F869q486238540128%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Physical exercise exerts a wide range of benefits on an organism’s overall health and well-being. Exercise contributes positively
 toward an individual’s healthy weight, muscle strength, immune system, and cardiovascular health. Indeed, exercise has been
 demonstrated to reduce life-threatening conditions such as high blood pressure, heart disease, obesity, and diabetes. Of particular
 interest to this review, exercise has also been shown to be neuroprotective in both the central and peripheral nervous systems.
 Naturally, such findings apply broadly to the study of neurodegenerative disease with numerous reports demonstrating that
 exercise has beneficial effects on disease progression. One of the most devastating neurodegenerative diseases is amyotrophic
 lateral ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1250531</comments>
            <pubDate>Wed, 20 Feb 2008 16:07:12 +0100</pubDate>
            <guid isPermaLink="false">1250531</guid>        </item>
        <item>
            <title>Physical Activity and the Regulation of Neurogenesis in the Adult and Aging Brain</title>
            <link>http://www.medworm.com/index.php?rid=1250527&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F07x8jp6315p270n2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The discovery that exercise regulates adult hippocampal neurogenesis, that is, the production of new neurons in the adult
 brain, was surprising news and changed quite fundamentally our view on how physical activity affects the brain. The everyday
 experience that not all athletes are necessarily smarter than more sedentary fellows and the scientific insight that adult
 hippocampal neurogenesis is actually a process that ranges on a very small scale raised important questions on the relevance
 of this finding. We propose that the exercise-related regulation of adult hippocampal neurogenesis is a qualitative rather
 than a quantitative event and that it is a particularly prominent and suggestive example of activity-dependent cellular plasticity.
 For rodents, the animals...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1250527</comments>
            <pubDate>Wed, 20 Feb 2008 16:07:10 +0100</pubDate>
            <guid isPermaLink="false">1250527</guid>        </item>
        <item>
            <title>Neurogenesis and Exercise: Past and Future Directions</title>
            <link>http://www.medworm.com/index.php?rid=1250530&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy151875715540800%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Research in humans and animals has shown that exercise improves mood and cognition. Physical activity also causes a robust
 increase in neurogenesis in the dentate gyrus of the hippocampus, a brain area important for learning and memory. The positive
 correlation between running and neurogenesis has raised the hypothesis that the new hippocampal neurons may mediate, in part,
 improved learning associated with exercise. The present review gives an overview of research pertaining to exercise-induced
 cell genesis, its possible relevance to memory function and the cellular mechanisms that may be involved in this process.
 
	Content Type Journal ArticleCategory Review PaperDOI 10.1007/s12017-008-8028-zAuthors
		Henriette van Praag, GRC/NIA/NIH Section of Neuroplasticity and...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1250530</comments>
            <pubDate>Wed, 20 Feb 2008 16:07:08 +0100</pubDate>
            <guid isPermaLink="false">1250530</guid>        </item>
        <item>
            <title>Growth Factors as Mediators of Exercise Actions on the Brain</title>
            <link>http://www.medworm.com/index.php?rid=1250529&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp665171685786172%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Physical exercise has long been recognized as highly beneficial for brain and body health. The molecular mechanisms responsible
 for translation of exercise stimuli in the brain have claimed attention due to mounting evidence for the neuroprotective actions
 of the exercise and its positive effects in preventing both ageing and neurodegenerative disease. These molecular mediators
 are currently under investigation with new tools able to yield deep insights into the neurobiology of exercise. In the present
 work we focus on the evidence pertaining to the mediation of exercise effects by insulin-like growth factor 1 (IGF1), as recent
 reports suggest that this growth factor shows brain area-specific, temporal rank-sensitive, and behavioural task-dependent
 features in res...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1250529</comments>
            <pubDate>Wed, 20 Feb 2008 16:07:08 +0100</pubDate>
            <guid isPermaLink="false">1250529</guid>        </item>
        <item>
            <title>Lack of Mitochondrial DNA Deletions in Lesions of Multiple Sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=1250528&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff5p1275155l48402%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;While aging and neurodegeneration in PD and AD are associated with accumulation of COX− cells and mtDNA deletions, the
 pathology of MS is not.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-008-8025-2Authors
		Andrei Blokhin, VA Medical Center, Research (151) Syracuse NY USATamara Vyshkina, VA Medical Center, Research (151) Syracuse NY USASamuel Komoly, Medical University of Pecs Pecs HungaryBernadette Kalman, VA Medical Center, Research (151) Syracuse NY USA
	

	
		Journal NeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084 (Source: NeuroMolecular Medicine)</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1250528</comments>
            <pubDate>Wed, 20 Feb 2008 16:07:08 +0100</pubDate>
            <guid isPermaLink="false">1250528</guid>        </item>
        <item>
            <title>Neuroplasticity of Dopamine Circuits After Exercise: Implications for Central Fatigue</title>
            <link>http://www.medworm.com/index.php?rid=1237146&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa2852t323411q347%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Habitual exercise increases plasticity in a variety of neurotransmitter systems. The current review focuses on the effects
 of habitual physical activity on monoamine dopamine (DA) neurotransmission and the potential implication of these changes
 to exercise-induced fatigue. Although it is clear that peripheral adaptations in muscle and energy substrate utilization contribute
 to this effect, more recently it has been suggested that central nervous system pathways “upstream” of the motor cortex, which
 initiate activation of skeletal muscles, are also important. The contribution of the brain to exercise-induced fatigue has
 been termed “central fatigue.” Given the well-defined role of DA in the initiation of movement, it is likely that adaptations
 in DA systems...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1237146</comments>
            <pubDate>Fri, 15 Feb 2008 17:58:04 +0100</pubDate>
            <guid isPermaLink="false">1237146</guid>        </item>
        <item>
            <title>Central Mechanisms of HPA Axis Regulation by Voluntary Exercise</title>
            <link>http://www.medworm.com/index.php?rid=1234886&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr2x5577137220453%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Stress exerts complex effects on the brain and periphery, dependent on the temporal profile and intensity of the stressor.
 The consequences of a stressful event can also be determined by other characteristics of the stressor, such as whether it
 is predictable and controllable. While the traditional view has focused primarily on the negative effects of stress on a variety
 of somatic systems, emerging data support the idea that certain forms of stress can enhance cellular function. Here we review
 the current literature on the hypothalamic-pituitary-adrenal (HPA) axis regulation by wheel running, a voluntary and controllable
 stressor with a distinct temporal profile. While running indeed activates a number of systems related to the stress response,
 other mechanisms e...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1234886</comments>
            <pubDate>Thu, 14 Feb 2008 16:08:18 +0100</pubDate>
            <guid isPermaLink="false">1234886</guid>        </item>
        <item>
            <title>Effects of Dietary Supplementation with N-Acetyl Cysteine, Acetyl-l
 -Carnitine and S-Adenosyl Methionine on Cognitive Performance and Aggression in Normal Mice and Mice Expressing Human ApoE4</title>
            <link>http://www.medworm.com/index.php?rid=1232124&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp46p211416g87jqm%2F</link>
            <description>Content Type Journal ArticleCategory ErratumDOI 10.1007/s12017-008-8024-3Authors
		Amy Chan, University of Massachusetts Lowell Center for Cellular Neurobiology &amp; Neurodegeneration Research Lowell MA 01854 USAThomas B. Shea, University of Massachusetts Lowell Center for Cellular Neurobiology &amp; Neurodegeneration Research Lowell MA 01854 USA
	

	
		Journal NeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084 (Source: NeuroMolecular Medicine)</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1232124</comments>
            <pubDate>Wed, 13 Feb 2008 16:09:52 +0100</pubDate>
            <guid isPermaLink="false">1232124</guid>        </item>
        <item>
            <title>DJ-1 is Essential for Long-Term Depression at Hippocampal CA1 Synapses</title>
            <link>http://www.medworm.com/index.php?rid=1198212&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv160081l25q57031%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations in DJ-1 cause inherited Parkinson’s disease (PD) in several families. The normal function of DJ-1 is unknown, but
 mice lacking DJ-1 exhibit a deficit in dopaminergic signaling in the striatum. Since the hippocampus contains relatively high
 levels of DJ-1, and PD patients are often cognitively impaired, we evaluated the effects of DJ-1 deficiency on the plasticity
 of hippocampal CA1 synapses. LTP was slightly impaired and LTD was abolished in DJ-1−/− mice, whereas DJ-1+/− mice exhibited
 no alterations in synaptic plasticity. The dopamine receptor D2/3 agonist quinpirole rescued LTD in DJ-1−/− mice, suggesting
 a role for impaired dopaminergic signaling in the hippocampal LTD deficit.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1198212</comments>
            <pubDate>Sat, 02 Feb 2008 16:47:17 +0100</pubDate>
            <guid isPermaLink="false">1198212</guid>        </item>
        <item>
            <title>Perturbed Autonomic Nervous System Function in Metabolic Syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1183089&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F03735278hw220525%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The metabolic syndrome is characterized by the clustering of various common metabolic abnormalities in an individual and it
 is associated with increased risk for the development of type 2 diabetes and cardiovascular diseases. Its prevalence in the
 general population is approximately 25%. Central fat accumulation and insulin resistance are considered as the common denominators
 of the abnormalities of the metabolic syndrome. Subjects with metabolic syndrome have autonomic nervous system dysfunction
 characterized by predominance of the sympathetic nervous system in many organs, i.e. heart, kidneys, vasculature, adipose
 tissue, and muscles. Sympathetic nervous system activation in metabolic syndrome is detected as increased heart rate and blood
 pressure, diminished he...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1183089</comments>
            <pubDate>Sat, 26 Jan 2008 16:31:22 +0100</pubDate>
            <guid isPermaLink="false">1183089</guid>        </item>
        <item>
            <title>Chronic Exposure to Dietary Sterol Glucosides is Neurotoxic to Motor Neurons and Induces an ALS–PDC Phenotype</title>
            <link>http://www.medworm.com/index.php?rid=1156106&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr4884968p801w8n5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Epidemiological studies of the Guamanian variants of amyotrophic lateral sclerosis (ALS) and parkinsonism, amyotrophic lateral
 sclerosis–parkinsonism dementia complex (ALS–PDC), have shown a positive correlation between consumption of washed cycad seed
 flour and disease occurrence. Previous in&amp;nbsp;vivo studies by our group have shown that the same seed flour induces ALS and PDC
 phenotypes in out bred adult male mice. In&amp;nbsp;vitro studies using isolated cycad compounds have also demonstrated that several
 of these are neurotoxic, specifically, a number of water insoluble phytosterol glucosides of which β-sitosterol β-d-glucoside (BSSG) forms the largest fraction. BSSG is neurotoxic to motor neurons and other neuronal populations in culture.
 The present study ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1156106</comments>
            <pubDate>Tue, 15 Jan 2008 16:12:47 +0100</pubDate>
            <guid isPermaLink="false">1156106</guid>        </item>
        <item>
            <title>Neurotrophic Factors in Autonomic Nervous System Plasticity and Dysfunction</title>
            <link>http://www.medworm.com/index.php?rid=1131291&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh1127g504q2h1060%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During development, neurotrophic factors are known to play important roles in regulating the survival of neurons in the autonomic
 nervous system (ANS) and the formation of their synaptic connectivity with their peripheral targets in the cardiovascular,
 digestive, and other organ systems. Emerging findings suggest that neurotrophic factors may also affect the functionality
 of the ANS during adult life and may, in part, mediate the effects of environmental factors such as exercise and dietary energy
 intake on ANS neurons and target cells. In this article, we describe the evidence that ANS neurons express receptors for multiple
 neurotrophic factors, and data suggesting that activation of those receptors can modify plasticity in the ANS. Neurotrophic
 factors that may ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1131291</comments>
            <pubDate>Thu, 03 Jan 2008 16:51:22 +0100</pubDate>
            <guid isPermaLink="false">1131291</guid>        </item>
        <item>
            <title>The Sympathetic Nervous System and Pain</title>
            <link>http://www.medworm.com/index.php?rid=1017953&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr11568834187048w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The sympathetic nervous system (SNS) and pain interact on many levels of the neuraxis. In healthy subjects, activation of
 the SNS in the brain usually suppresses pain mainly by descending inhibition of nociceptive transmission in the spinal cord.
 Furthermore, some experimental data even suggest that the SNS might control peripheral inflammation and nociceptive activation.
 However, even subtle changes in pathophysiology can dramatically change the effect of SNS on pain, and vice versa. In the
 periphery, inflammation or nociceptive activation is enhanced, spinal descending inhibition is reversed to spinal facilitation,
 and finally the awareness of all these changes will induce anxiety, which furthermore amplifies pain perception, affects pain
 behavior, and depresses...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1017953</comments>
            <pubDate>Thu, 08 Nov 2007 16:11:22 +0100</pubDate>
            <guid isPermaLink="false">1017953</guid>        </item>
        <item>
            <title>The Molecular Basis of Familial Dysautonomia: Overview, New Discoveries and Implications for Directed Therapies</title>
            <link>http://www.medworm.com/index.php?rid=1012545&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8368305518617738%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Familial dysautonomia (FD) is a sensory and autonomic neuropathy that affects the development and survival of sensory, sympathetic,
 and some parasympathetic neurons. It is autosomally inherited and occurs almost exclusively among individuals of Ashkenazi
 Jewish descent. The pathological and clinical manisfestations of FD have been extensively studied and therapeutic modalities
 have, until recently, focused primarily on addressing the symptoms experienced by those with this fatal disorder. The primary
 FD-causing mutation is an intronic nucleotide substitution that alters the splicing of the IKBKAP-derived transcript. Recent efforts have resulted in the development of new therapeutic modalities that facilitate the increased
 production of the correctly spliced transcr...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1012545</comments>
            <pubDate>Tue, 06 Nov 2007 15:53:14 +0100</pubDate>
            <guid isPermaLink="false">1012545</guid>        </item>
        <item>
            <title>Neurodegenerative Diseases: Neurotoxins as Sufficient Etiologic Agents?</title>
            <link>http://www.medworm.com/index.php?rid=1012546&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F029512742xx1642t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A dominant paradigm in neurological disease research is that the primary etiological factors for diseases such as Alzheimer’s
 (AD), Parkinson’s (PD), and amyotrophic lateral sclerosis (ALS) are genetic. Opposed to this perspective are the clear observations
 from epidemiology that purely genetic casual factors account for a relatively small fraction of all cases. Many who support
 a genetic etiology for neurological disease take the view that while the percentages may be relatively small, these numbers
 will rise in the future with the inevitable discoveries of additional genetic mutations. The follow up argument is that even
 if the last is not true, the events triggered by the aberrant genes identified so far will be shown to impact the same neuronal
 cell death ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1012546</comments>
            <pubDate>Tue, 06 Nov 2007 15:53:13 +0100</pubDate>
            <guid isPermaLink="false">1012546</guid>        </item>
        <item>
            <title>Nonsynonymous Polymorphisms of Histamine-Metabolising Enzymes in Patients with Parkinson’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=1012547&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy55232l51185153t%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;These results, combined with previous findings indicating alterations in histamine levels in patients with PD, suggest
 that alterations of histamine homeostasis in the SNC are associated with the risk for PD.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-007-8017-7Authors
		José A. G. Agúndez, University of Extremadura Department of Pharmacology &amp; Psychiatry, Medical School Badajoz SpainAntonio Luengo, University Hospital La Princesa Service of Neurology Madrid SpainOscar Herráez, University of Extremadura Department of Pharmacology &amp; Psychiatry, Medical School Badajoz SpainCarmen Martínez, University of Extremadura Department of Pharmacology &amp; Psychiatry, Medical School Badajoz SpainHortensia Alonso-Navarro, Príncipe de As...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1012547</comments>
            <pubDate>Tue, 06 Nov 2007 15:53:05 +0100</pubDate>
            <guid isPermaLink="false">1012547</guid>        </item>
        <item>
            <title>Increased T-cell Reactivity and Elevated Levels of CD8+ Memory T-cells in Alzheimer’s Disease-patients and T-cell Hyporeactivity in an Alzheimer’s Disease-mouse Model: Implications for Immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=992151&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl12988721r47j823%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neuroinflammation is observed in neurodegenerative diseases like Alzheimer’s disease (AD). However, a little is known about
 the mechanisms of neural-immune interactions. The involvement of peripheral T-cell function in AD is still far from clear,
 though it plays an important role in immunotherapy. The aim of this study was to determine peripheral T-cell reactivity in
 AD patients and in an AD mouse model. Mitogenic activation via ligation of the T-cell receptor (TCR) with PHA-L was measured
 in T lymphocytes from AD patients and Thy1(APP751SL)&amp;nbsp;�&amp;nbsp;HMG(PS1M146L)-transgenic mice (APP&amp;nbsp;�&amp;nbsp;PS1). In order to uncover failures in TCR signaling, the TCR was also bypassed by PMA and ionomycin
 treatment. All patients were sporadic late onset cases and the...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=992151</comments>
            <pubDate>Fri, 26 Oct 2007 14:28:08 +0100</pubDate>
            <guid isPermaLink="false">992151</guid>        </item>
        <item>
            <title>A Cytoskeleton Motor Protein Genetic Variant May Exert a Protective Effect on the Occurrence of Multiple Sclerosis: The Janus Face of the Kinesin Light-Chain 1 56836CC Genetic Variant</title>
            <link>http://www.medworm.com/index.php?rid=956303&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F960tu76503501442%2F</link>
            <description>In this study, we examined how the kinesin light-chain 1 (KLC1) G56836C (rs8702) single nucleotide
 polymorphism (SNP) in intron 13 affects the occurrence of MS. This genetic variant was found to be associated with cognitive
 disturbances and neurodegeneration, and it was presumed to affect the kinesin function. Kinesin serves as a main cytoskeleton
 motor protein by carrying mitochondria and the molecular apparatus of myelin basic protein synthesis. The present association
 analysis of this genetic variant was performed in 102 relapsing-remitting MS patients and in 207 neuroimaging alteration-free
 controls. The KLC1 56836CC variant proved to exert a significant protective effect on the occurrence of MS (2.0% vs. 9.7%,
 P&amp;nbsp;&amp;lt;&amp;nbsp;0.02; crude OR: 0.19, 95% CI: 0.04–0.82, P&amp;nbsp;&amp;l...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=956303</comments>
            <pubDate>Sat, 13 Oct 2007 17:27:54 +0100</pubDate>
            <guid isPermaLink="false">956303</guid>        </item>
        <item>
            <title>Complement Factor H Y402H Polymorphism is not Associated with Late-onset Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=903890&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F26622q351q0001gt%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is evidence to suggest a role for immune dysfunction in the pathogenesis of Alzheimer’s disease, and it has previously
 been shown that blood plasma levels of the protein complement factor H, a member of the alternative complement pathway, was
 specifically elevated in people with late-onset Alzheimer’s disease. We have genotyped the common complement factor H Y402H
 polymorphism in a large case–control cohort to investigate association with late-onset Alzheimer’s disease susceptibility
 and find no evidence that this SNP is associated with disease risk. However, it remains possible that another variant in this
 gene may modify susceptibility for late-onset Alzheimer’s disease.
 
	Content Type Journal ArticleCategory Original PaperDOI 10.1007/s12017-007-...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=903890</comments>
            <pubDate>Sun, 23 Sep 2007 17:53:58 +0100</pubDate>
            <guid isPermaLink="false">903890</guid>        </item>
        <item>
            <title>Lipoproteins Obtained from Anorexia Nervosa Patients Induce Higher Oxidative Stress in U373MG Astrocytes Through Nitric Oxide Production</title>
            <link>http://www.medworm.com/index.php?rid=880398&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F06mh177p78351180%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Eating disorders (ED) are a group of important psychiatric disorders that affect young men and women, and can have serious
 consequences. Among all ED, anorexia nervosa (AN) is the most typical but also the most severe. The pathogenesis of AN is
 multifactorial and a great variety of cognitive deficits may contribute to its pathogenesis. The present study is aimed to
 measure NO and peroxynitrite production, iNOS and nNOS expression by Western immunoblot after incubation of AN lipoproteins
 at different times with human astrocytoma cells. The AN-HDL treated cells showed an increased production of NO at 3&amp;nbsp;h versus
 control-HDL treated cells and a decreased production at 24&amp;nbsp;h. Regarding LDL, a significant increase of NO production was obtained
 both at 3 and 24&amp;...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=880398</comments>
            <pubDate>Mon, 17 Sep 2007 17:42:22 +0100</pubDate>
            <guid isPermaLink="false">880398</guid>        </item>
        <item>
            <title>Western Style Diet Impairs Entrance of Blood-Borne Insulin-like Growth Factor-1 into the Brain</title>
            <link>http://www.medworm.com/index.php?rid=846021&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2r3562wn2w354981%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is increasingly recognized that life-style factors, such as physical exercise or diet influence brain health. In the present
 work we analyzed the effect of a western-style diet (“cafeteria diet”) on the entrance to the brain of circulating IGF-1,
 a neuroprotective agent that has been related to different neurodegenerative diseases. Rats under a cafeteria diet showed
 reduced passage of systemic IGF-1 across the choroid plexus, a main site of IGF-1 entrance into the brain through the cerebrospinal
 fluid. Furthermore, the IGF-1 receptor at the choroid plexus of rats fed with a cafeteria diet showed enhanced sensitivity
 toward IGF-1 while receptor levels remained unchanged. Examination of possible mechanisms underlying reduced entrance of systemic
 IGF-1 to the ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=846021</comments>
            <pubDate>Wed, 05 Sep 2007 07:18:14 +0100</pubDate>
            <guid isPermaLink="false">846021</guid>        </item>
        <item>
            <title>Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in alzheimer disease</title>
            <link>http://www.medworm.com/index.php?rid=833750&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4044865786811v65%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;One of the main hallmarks of Alzheimer’s disease (AD) is the brain deposition of senile plaques made up of toxic amyloid β-peptide
 (Aβ), which is derived from a larger protein called the β-amyloid precursor protein (APP). Both APP processing and cholinesterase
 activity are affected in the AD brain, but, yet, cholinesterase inhibitors (ChEI) remain the primary Food and Drug Administration
 approved drugs for AD within the United States. Herein, we evaluated the effects of two clinically relevant drugs on the APP
 pathway, which is presumably involved in AD pathogenesis. Specifically, we compared the actions of the classical ChEI physostigmine
 (PHY) and its analog phenserine (PHE) on neuronal cell viability, on IC50 and on levels of different amyloid proteins. Int...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833750</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:02 +0100</pubDate>
            <guid isPermaLink="false">833750</guid>        </item>
        <item>
            <title>Investigation of RNA interference to suppress expression of full-length and fragment human huntingtin</title>
            <link>http://www.medworm.com/index.php?rid=833753&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuu0k4082452t0848%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The use of RNA interference (RNAi) to suppress the expression of genes has drastically improved the ability to examine gene
 function and is now being considered as a therapeutic approach for many diseases including genetic forms of neurodegenerative
 disease. Recently, research has focused on RNAi for the treatment of Huntington’s and other polyglutamine diseases. In this
 work we explored the efficacy and specificity of short hairpin RNAs to target human huntingtin mRNA. We found two sequences
 that are specific for, and efficiently suppress human huntingtin mRNA. Mouse cell lines that stably harbored human short hairpin
 RNA constructs specifically inhibited the expression of human huntingtin supplied by transfected expression plasmids. However,
 these same constru...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833753</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:01 +0100</pubDate>
            <guid isPermaLink="false">833753</guid>        </item>
        <item>
            <title>Brain tumor formation in tuberous sclerosis depends on erk activation</title>
            <link>http://www.medworm.com/index.php?rid=833752&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb20041m8276r6308%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tuberous sclerosis (TS) is an autosomal dominant disease associated with the formation of usually benign tumors or hamartomas.
 The disease is connected with upregulation of mammalian target of rapamycin, central regulator of protein translation, which
 is usually regarded to be activated by Akt kinase. Here, we show for the first time that in all four brain lesions and one
 angiomyolipoma from TS patients both extracellular signal-regulated kinase (Erk) and p90 ribosomal S6 kinase 1 activation
 as well as Erk-dependent phosphorylation of p70 ribosomal S6 kinase 1 are markedly elevated whereas Akt, participating in
 the classical pathway of mammalian target of rapamycin activation is not always activated. Erk activation is also present
 in TS-derived cell lines. Importa...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833752</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:01 +0100</pubDate>
            <guid isPermaLink="false">833752</guid>        </item>
        <item>
            <title>Increased expression of caspase 2 in experimental and human temporal lobe epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=833751&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk8322252413x61l4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Temporal lobe epilepsy (TLE) is often caused by a neurodegenerative brain insult that triggers epileptogenesis, and eventually
 results in spontaneous seizures, i.e., epilepsy. Understanding the mechanisms of cell death is a key for designing new drug
 therapies for preventing the neurodegeneration associated with TLE. Here, we investigated the expression of caspase 2, a protein
 involved in programmed cell death, during the course of epilepsy. We investigated caspase 2 expression in hippocampal samples
 derived from patients operated on for drug refractory TLE. To understand the evolution of altered-caspase 2 expression during
 the epileptic process, we also examined caspase 2 expression and activity in the rat hippocampus after status epilepticus-induced
 acute damage...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833751</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:01 +0100</pubDate>
            <guid isPermaLink="false">833751</guid>        </item>
        <item>
            <title>A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder</title>
            <link>http://www.medworm.com/index.php?rid=833748&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F368w08241133r18k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The identification of the genetic variants underpinning bipolar disorder (BPD) has been impeded by a complex pattern of inheritance
 characterized by genetic and phenotypic heterogeneity, genetic epistasis, and gene-environment interactions. In this paper
 two strategies were used to ameliorate these confounding factors. A unique South African sample including 190 individuals
 of the relatively, reproductively isolated Afrikaner population was assessed with a battery of neuropsychological tests in
 an attempt to identify a BPD-associated quantitative trait or endophenotype. BPD individuals performed significantly worse
 than their unaffected relatives on visual and verbal memory tasks, a finding congruent with the literature. A focused linkage
 and family-based associat...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833748</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:01 +0100</pubDate>
            <guid isPermaLink="false">833748</guid>        </item>
        <item>
            <title>Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor</title>
            <link>http://www.medworm.com/index.php?rid=833755&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa7270r70j4016182%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To identify low-penetrance genes related to sporadic essential tremor (ET) at the CYP2Clocus, located in chromosome 10 q23.33. Leukocytary DNA from 200 ET patients and a control group of 300 unrelated healthy
 individuals with known CYP2C19 genotypes was studied for common CYP2C8 and CYP2C9 allelic variants by using amplification-restriction analyses. Patients with ET showed the following differences compared
 with healthy subjects: a 1.6-fold reduction in the frequency for CYP2C8*3 (p=0.006), a 1.35-fold reduction of CYP2C9*2 (p=0.05) and a 1.52-fold reduction in the frequency for CYP2C9*3 (p=0.07). The frequency for patients with ET carrying at least one defective allele was 1.33-fold reduced as compared with healthy
 subjects (p=0.002). In addition, a disruption of t...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833755</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:00 +0100</pubDate>
            <guid isPermaLink="false">833755</guid>        </item>
        <item>
            <title>HIV-1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-κB-dependent mechanism</title>
            <link>http://www.medworm.com/index.php?rid=833754&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft25042x889524254%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Human immunodeficiency virus-1 gp120 alters astroglial function, which compromises the function of the nearby of neuronal
 cells contributing to the cognitive impairment in human immunodeficiency virus-1 infection. Cyclooxygenase (COX)-2 has been
 involved in this process, although the intracellular pathways and second messengers involved are yet unknown. We have investigated
 the role of gp120-induced COX-2 in the astrocytoma human cell line U-87, and the different pathways involved in this activation.
 COX-2 mRNA and protein expression were detected in gp120-stimulated cells. Moreover, gp120 induces COX-2 promoter transcription.
 The effect of gp120 was abrogated by a neutralizing antibody against the chemokine receptor CXCR4 neutralizing antibody. Analysis
 of the pr...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833754</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:00 +0100</pubDate>
            <guid isPermaLink="false">833754</guid>        </item>
        <item>
            <title>Association analyses of the DAOA/G30 and d
 -amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=833749&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj3t3356222337615%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A number of linkage studies have previously implicated the region of chromosome 13q34 in schizophrenia. Chumakov and colleagues
 (2002) identified a gene complex called G72 (now termed d-amino acid oxidase activator: DAOA)/G30 in this region and performed association analyses of the DAOA/G30 as well as the d-amino-acid oxidase (DAAO) gene with schizophrenia. DAAO oxidizes d-serine, a potent activator of the N-methyl-d-aspartate (NMDA) type glutamate receptor in the human brain whereas the DAOA protein is considered an activator of DAAO.
 The interaction of these two genes has thus been implicated in the NMDA receptor regulation pathway in schizophrenia. To date,
 several studies have shown a relatively consistent positive association between schizophrenia and DAOA/G30, ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=833749</comments>
            <pubDate>Thu, 30 Aug 2007 07:51:00 +0100</pubDate>
            <guid isPermaLink="false">833749</guid>        </item>
        <item>
            <title>Effects of Dietary Supplementation with N-Acetyl Cysteine, Acetyl-l
 -Carnitine and S-Adenosyl Methionine on Cognitive Performance and Aggression in Normal Mice and Mice Expressing Human ApoE4</title>
            <link>http://www.medworm.com/index.php?rid=815379&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp07r012581633836%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In addition to cognitive impairment, behavioral changes such as aggressive behavior, depression, and psychosis accompany Alzheimer’s
 Disease. Such symptoms may arise due to imbalances in neurotransmitters rather than overt neurodegeneration. Herein, we demonstrate
 that combined administration of N-acetyl cysteine (an antioxidant and glutathione precursor that protects against Abeta neurotoxicity),
 acetyl-l-carnitine (which raises ATP levels, protects mitochondria, and buffers Abeta neurotoxicity), and S-adenosylmethionine (which
 facilitates glutathione usage and maintains acetylcholine levels) enhanced or maintain cognitive function, and attenuated
 or prevented aggression, in mouse models of aging and neurodegeneration. Enhancement of cognitive function was rapid...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=815379</comments>
            <pubDate>Tue, 21 Aug 2007 07:12:58 +0100</pubDate>
            <guid isPermaLink="false">815379</guid>        </item>
        <item>
            <title>Differential Regulation of Smac/DIABLO and Hsp-70 during Brain Maturation</title>
            <link>http://www.medworm.com/index.php?rid=815380&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff075318j56378411%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The heat shock protein (Hsp) system is a cell defense mechanism constitutively expressed at the basal state and essential
 for cell survival in response to damaging stimuli. Apoptosis is a physiological cell death program that preserves tissue homeostasis.
 We investigated the intrinsic pathway of apoptosis at various stages of brain maturation in CD-1 mice, triggered by two mitochondrial
 proapoptotic proteins, cytochrome c and Smac/DIABLO, and the pathway’s regulation by Hsp-70. Smac/DIABLO and Hsp-70 proteins were upregulated 2-fold and 1.5–3-fold,
 respectively, after birth. In contrast, in the presence of cytochrome c/2′-deoxyadenosine 5′-triphosphate (dATP), caspase activity in mouse brain cell-free extracts increased 90-fold and 61-fold,
 at fetal and neo...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=815380</comments>
            <pubDate>Tue, 21 Aug 2007 07:12:57 +0100</pubDate>
            <guid isPermaLink="false">815380</guid>        </item>
        <item>
            <title>NR1 Knockdown Reveals CA1 Injuryduring a Developmental Period of High Seizure Susceptibility Despite Reduced Seizure Activity</title>
            <link>http://www.medworm.com/index.php?rid=800214&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc76620q7322njxl1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;NMDA receptors (NMDARs) are important for the propagation of seizures. To understand the role of NR1 subunits in the propagation
 of seizures we knocked down the NR1 subunit by intracranial injection of antisense deoxyoligonucleotides (NR1-AS-ODNs) into
 the right hippocampus during a window of maximal seizure susceptibility in development. Control missense and sense ODNs followed
 by focal injection of NMDA (2.5–25&amp;nbsp;nmoles) into the hippocampal CA1 and sensorimotor cortex of P15 rat pups resulted in behavioral
 and electrographic (EEG) seizures. After NR1 knockdown, low- and high-doses produced little or no spike activity in the hippocampus
 and overlying sensorimotor cortex as predicted. Despite reduced activity in the hippocampal and cortical EEG, intracranial
...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=800214</comments>
            <pubDate>Tue, 14 Aug 2007 07:30:43 +0100</pubDate>
            <guid isPermaLink="false">800214</guid>        </item>
        <item>
            <title>Magnetic Resonance Microscopy and Immunohistochemistry of the CNS of the Mutant SOD Murine Model of ALS Reveals Widespread Neural Deficits</title>
            <link>http://www.medworm.com/index.php?rid=800213&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl35w645844xl5672%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that primarily affects motor neurons and descending motor
 tracts of the CNS. We have evaluated the CNS of a murine model of familial ALS based on the over-expression of mutant human
 superoxide dismutase (mSOD; G93A) using magnetic resonance microscopy (MRM) and immunohistochemistry (IHC). Three-dimensional
 volumetric analysis was performed from 3D T2*-weighted images acquired at 17.6 T at isotropic resolutions of 40&amp;nbsp;μm. Compared to controls, mSOD mice had significant reductions
 in the volumes of total brain, substantia nigra, striatum, hippocampus, and internal capsule, with decreased cortical thickness
 in primary motor and somatosensory cortices. In the spinal cord, mSOD mice had significantl...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=800213</comments>
            <pubDate>Tue, 14 Aug 2007 07:30:43 +0100</pubDate>
            <guid isPermaLink="false">800213</guid>        </item>
        <item>
            <title>Soluble Neuroprotective Antioxidant Uric Acid Analogs Ameliorate Ischemic Brain Injury in Mice</title>
            <link>http://www.medworm.com/index.php?rid=795903&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk20158m6401q401h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Uric acid is a major antioxidant in the blood of humans that can protect cultured neurons against oxidative and metabolic
 insults. However, uric acid has a very low solubility which compromises its potential clinical use for neurodegenerative disorders.
 Here we describe the synthesis, characterization and preclinical development of neuroprotective methyl- and sulfur-containing
 analogs of uric acid with increased solubility. In&amp;nbsp;vitro and cell culture screening identified 1,7-dimethyluric acid (mUA2)
 and 6,8-dithiouric acid (sUA2) as two analogs with high antioxidant and neuroprotective activities. When administered intravenously
 in mice, uric acid analogs mUA2 and sUA2 lessened damage to the brain and improved functional outcome in an ischemia-reperfusion
 mous...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795903</comments>
            <pubDate>Fri, 10 Aug 2007 07:13:06 +0100</pubDate>
            <guid isPermaLink="false">795903</guid>        </item>
        <item>
            <title>Pore-Forming Proteins Share Structural and Functional Homology with Amyloid Oligomers</title>
            <link>http://www.medworm.com/index.php?rid=795904&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0m69w52717006350%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Degenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases are believed to be causally related to the
 accumulation of amyloid oligomers that exhibit a common structure and may be toxic by a common mechanism involving permeabilization
 of membranes. We discovered that amyloid oligomers and the pore-forming bacterial toxin, α-hemolysin (αHL), as well as human
 perforin from cytotoxic T lymphocytes, share a structural and functional homology at the level of their common reactivity
 with a conformation-dependent antibody that is specific for amyloid oligomers, A11. The αHL oligomeric pores and partially
 folded αHL protomer, but not the monomer αHL precursor reacts with A11 antibody. A11 antibody inhibits the hemolytic activity
 of αHL, i...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795904</comments>
            <pubDate>Thu, 09 Aug 2007 12:25:07 +0100</pubDate>
            <guid isPermaLink="false">795904</guid>        </item>
        <item>
            <title>Gene-targeting technologies for the study of neurological disorders</title>
            <link>http://www.medworm.com/index.php?rid=795913&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy8475064v7k1n7m4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Studies using genetic manipulations have proven invaluable in the research of neurological disorders. In the forefront of
 these approaches is the knockout technology that engineers a targeted gene mutation in mice resulting in inactivation of gene
 expression. In many cases, important roles of a particular gene in embryonic development have precluded the in vivo study
 of its function in the adult brain, which is usually the most relevant experimental context for the study of neurological
 disorders. The conditional knockout technology has provided a tool to overcome this restriction and has been used successfully
 to generate viable mouse models with gene inactivation patterns in certain regions or cell types of the postnatal brain. This
 review first describes the me...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795913</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:54 +0100</pubDate>
            <guid isPermaLink="false">795913</guid>        </item>
        <item>
            <title>Calcium-regulated signaling pathways</title>
            <link>http://www.medworm.com/index.php?rid=795912&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8240twu68j1w1370%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyloid β (Aβ) peptides have been shown to impair synaptic function, especially long-term synaptic plasticity, in transgenic
 mouse models of Alzheimer’s disease (AD) and in acute hippocampal preparations. In the transgenic mice overexpressing mutant
 forms of human amyloid precursor protein (APP), the deficits in hippocampal long-term potentiation (LTP) occur prior to synaptic
 loss and cell death, suggesting early functional changes at these synapses. Recent studies demonstrate that Aβ-induced synaptic
 dysfunction is linked with altered Ca2+ signaling in hippocampal neurons. While reducing Ca2+ influx through NMDA receptors, Aβ peptides elevate intracellular Ca2+ concentration by enhancing Ca2+ influx from voltage-gated Ca2+ channels or nonselective cation chan...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795912</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:54 +0100</pubDate>
            <guid isPermaLink="false">795912</guid>        </item>
        <item>
            <title>Dietary supplementation with 3-deaza adenosine, 
 N
 -acetyl cysteine, and 
 S
 -adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge</title>
            <link>http://www.medworm.com/index.php?rid=795916&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7853214515473434%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Folate deprivation induces neurotoxicity that is potentiated by additional nutritional and genetic deficiencies including
 vitamin E and apolipoprotein E deficiency. These deficiencies collectively induce oxidative damage, cognitive impairment,
 and compensatory alteration in glutathione generation. Treatment with agents that regulate distinct portions of the methionine
 cycle, including the S-adenosyl homocysteine hydrolase inhibitor, 3-deaza adenosine, the methyl donor S-adenosyl methionine, and the antioxidant N-acetyl cysteine, provide neuroprotection against various aspects of neurotoxicity in normal and apolipoprotein E-deficient
 mice and in cultured neuronal cells deprived of dietary folate and vitamin E and subjected to iron overload. Here it is demonstrated
 t...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795916</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:53 +0100</pubDate>
            <guid isPermaLink="false">795916</guid>        </item>
        <item>
            <title>Numb modifies neuronal vulnerability to amyloid β-peptide in an isoform-specific manner by a mechanism involving altered calcium homeostasis</title>
            <link>http://www.medworm.com/index.php?rid=795920&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmw63n60081545r23%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Increased production of neurotoxic forms of amyloid β-peptide (Aβ) and abnormalities in neuronal calcium homeostasis play
 central roles in the pathogenesis of Alzheimer’s disease (AD). Notch, a membrane receptor that controls cell-fate decisions
 during development of the nervous system, has been linked to AD because it is a substrate for the γ-secretase enzyme activity
 that involves the presenilin-1 (PS1) protein in which mutations cause early-onset inherited AD. The actions of Notch can be
 antagonized by Numb, an evolutionarily conserved protein that exists in four isoforms that differ in two functional domains:
 a phosphotyrosine-binding (PTB) domain and a proline-rich region (PRR). We now report that Numb isoforms containing a short
 PTB domain increase the ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795920</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:52 +0100</pubDate>
            <guid isPermaLink="false">795920</guid>        </item>
        <item>
            <title>Cell-free generation of the Notch1 intracellular domain (NICD) and APP-CTFγ</title>
            <link>http://www.medworm.com/index.php?rid=795917&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F542n22j414u61685%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 PSEN1 and PSEN2 encode polytopic membrane proteins, termed presenilin 1 (PS1) and presenilin 2 (PS2) that play an essential role in intramembranous
 (“γ-secretase”) proteolysis of selected type I membrane proteins, that include Notch1 and β-amyloid precursor protein (APP).
 In order to gain insights into biochemical mechanisms underlying γ-secretase processing of Notch1 and APP, we have developed
 a novel in vitro assay in which γ-secretase-mediated generation of S3/NICD and APP-CTFγ can be readily detected in isolated
 membrane fractions derived from immortalized PS1+/− mouse embryonic fibroblasts; production of the APP and Notch1 derivatives
 are inhibited by a highly selective and potent γ-secretase inhibitor, L-685,458, with a IC50 of ∼50 pM. In memb...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795917</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:52 +0100</pubDate>
            <guid isPermaLink="false">795917</guid>        </item>
        <item>
            <title>Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in 
 SCA1
 transgenic mice</title>
            <link>http://www.medworm.com/index.php?rid=795908&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv051981k606j5440%2F</link>
            <description>In this report, the pathological importance of a segment of
 ataxin-1 previously shown to be important for protein-protein interactions was examined. While the absence of a 122 amino
 acid segment from the protein-protein interaction region of ataxin-1 did not effect the initiation of disease, its absence
 substantially suppressed the progression of disease in SCA1 transgenic mice. Thus, these data suggest that this region of ataxin-1 has a role in disease progression. Furthermore, these
 results provide evidence that ataxin-1-induced disease initiation and disease progression involve distinct molecular events.
 
	Content TypeJournal Article

	
		JournalNeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084
	
		Journal VolumeVolume 1
	
		Journal IssueVolume 1, Number 1 / February...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795908</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:52 +0100</pubDate>
            <guid isPermaLink="false">795908</guid>        </item>
        <item>
            <title>Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour</title>
            <link>http://www.medworm.com/index.php?rid=795919&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb851g838705l004x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Consumption of cycad seed products (Cycas circinalis) is one of the strongest epidemiological links to the Guamian neurological disorder amyotrophic lateral sclerosis-parkinsonism-dementia
 complex (ALS-PDC), however, the putative toxin which causes neurodegeneration has never been identified definitively. To reexamine
 this issue, 6–7-mo-old, male CD-1 mice were assessed for motor and cognitive behaviours during and following feeding with
 pellets made from washed cycad flour. Cycad-fed animals showed early evidence of progressive motor and cognitive dysfunctions.
 Neurodegeneration measured using TUNEL and caspase-3 labeling was found in neocortex, various hippocampal fields, substantia
 nigra, olfactory bulb, and spinal cord. In vitro studies using rat neocortex ha...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795919</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:51 +0100</pubDate>
            <guid isPermaLink="false">795919</guid>        </item>
        <item>
            <title>PLAIDD, a type II death domain protein that interacts with p75 neurotrophin receptor</title>
            <link>http://www.medworm.com/index.php?rid=795918&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk62h4pkv52085277%2F</link>
            <description>We describe the cloning and characterization of a rat single transmembrane protein that is homologous to the common neurotrophin
 receptor p75NTR in its death domain and the transmembrane region but dissimilar outside these regions. We have dubbed this protein PLAIDD,
 for p75-like apoptosis-inducing death domain protein. PLAIDD messenger RNA, which is ubiquitously distributed, is highly expressed
 in the embryo, but downregulated in adult tissues. Alternative splicing within the extracellular region of PLAIDD generates
 four RNA species, but only two of them are translated, PLAIDD_L and PLAIDD_S (long and short isoforms, respectively). While
 the amino acid sequence of the intracellular region of PLAIDD displays 41% identity with the intracellular region of p75NTR, the extracellular regio...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795918</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:51 +0100</pubDate>
            <guid isPermaLink="false">795918</guid>        </item>
        <item>
            <title>Book review</title>
            <link>http://www.medworm.com/index.php?rid=795911&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3246148282k5g242%2F</link>
            <description>Content TypeJournal Article

	
		JournalNeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084
	
		Journal VolumeVolume 2
	
		Journal IssueVolume 2, Number 1 / August, 2002 (Source: NeuroMolecular Medicine)</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795911</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:51 +0100</pubDate>
            <guid isPermaLink="false">795911</guid>        </item>
        <item>
            <title>Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?</title>
            <link>http://www.medworm.com/index.php?rid=795921&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9h6034546q373811%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Signals between neurons are transduced primarily by receptors, and second messenger and kinase cascades, located in pre- and
 postsynaptic terminals. Such synaptic signaling pathways include those activated by neurotransmitters, cytokines, neurotrophic
 factors, and cell-adhesion molecules. Many of these signaling systems are also localized in the growth cones of axons and
 dendrites, where they control pathfinding and synaptogenesis during development. Although it has been known for decades that
 such signaling pathways can affect the survival of neurons, by promoting or preventing a form of programmed cell death known
 as apoptosis, we have discovered that apoptotic biochemical cascades can exert local actions on the functions and structural
 dynamics of growth cones ...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795921</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:50 +0100</pubDate>
            <guid isPermaLink="false">795921</guid>        </item>
        <item>
            <title>Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain</title>
            <link>http://www.medworm.com/index.php?rid=795906&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Faj47295787343096%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Inflammatory processes involving glial cell activation are associated with amyloid plaques and neurofibrillary tangles, the
 cardinal neuropathological lesions in the brains of Alzheimer’s disease (AD) patients, However, it is unclear whether these
 inflammatory processes occur as a response to neuronal degeneration or might represent more seminal events in the disease
 process. Some cases of AD are caused by mutations in presenilin-1 (PS1), and it has been shown that PS1 mutations perturb
 neuronal calcium homeostasis, promote increased production of amyloid β-peptide (Aβ), and render neurons vulnerable to synaptic
 dysfunction, excitotoxicity, and apoptosis. Although glial cells express PS1, it is not known if PS1 mutations alter glial
 cell functions. We now repo...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795906</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:50 +0100</pubDate>
            <guid isPermaLink="false">795906</guid>        </item>
        <item>
            <title>Alpha-synuclein and presynaptic function</title>
            <link>http://www.medworm.com/index.php?rid=795922&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0808x938p163n185%2F</link>
            <description>This article focuses on α-synuclein’s role in normal and pathological axonal and presynaptic functions and its relationship
 to Parkinson’s disease. It is not possible to mention all the contributions to aspects of this area. Readers interested in
 α-synuclein’s relation to aggregation, Lewy lesions, and pathological modifications are referred to the many reviews (see Goldberg and Lansbury 2000; Galvin 2001a; Goedert 2001).
 
	Content TypeJournal Article

	
		JournalNeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084
	
		Journal VolumeVolume 2
	
		Journal IssueVolume 2, Number 2 / October, 2002 (Source: NeuroMolecular Medicine)</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795922</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:49 +0100</pubDate>
            <guid isPermaLink="false">795922</guid>        </item>
        <item>
            <title>Fast axonal transport misregulation and Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=795915&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy163827040h78148%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pathological alterations in the microtubule-associated protein (MAP) tau are well-established in a number of neurodegenerative
 disorders, including Alzheimer’s Disease (AD), frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), and others.
 Tau protein and in some cases, neurofilament subunits exhibit abnormal phosphorylation on specific serine and threonine residues
 in these diseases. A large body of biochemical, genetic, and cell biological evidence implicate two major serine-threonine
 protein kinases, glycogen synthase kinase 3 (GSK-3) and cyclin-dependent kinase 5 (CDK5) as major kinases responsible for
 both normal and pathological phosphorylation of tau protein in vivo. What remains unclear is whether tau phosphorylation and/or
 neurofibrillary...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795915</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:49 +0100</pubDate>
            <guid isPermaLink="false">795915</guid>        </item>
        <item>
            <title>Tau and axonopathy in neurodegenerative disorders</title>
            <link>http://www.medworm.com/index.php?rid=795907&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg01wwn21w0134615%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The microtubule (MT)-associated protein (MAP) tau in neurons has been implicated as a significant factor in the axonal growth,
 development of neuronal polarity, and the maintenance of MT dynamics. Tau is localized to the axon, and is known to promote
 MT assembly and to stabilize axonal MTs. These functions of tau are primarily regulated by the activities of protein kinases
 and phosphatases. In Alzheimer’s disease and other neurodegenerative disorders, abundant filamentous tau inclusions are found
 to be major neuropathological characteristics of these diseases. Both somato-dendritic and axonal tau lesions appear to be
 closely associated with axonal disruption. Furthermore, recent discoveries of pathogenic mutations on the tau gene suggest
 that abnormalities of ta...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795907</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:49 +0100</pubDate>
            <guid isPermaLink="false">795907</guid>        </item>
        <item>
            <title>G protein-coupled receptor kinase/β-arrestin systems and drugs of abuse</title>
            <link>http://www.medworm.com/index.php?rid=795910&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn08910182xm31k8w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;G protein-coupled receptors (GPCRs) currently represent pharmaceutical targets for numerous medicinal compounds that are used
 to treat conditions ranging from blood pressure dysregulation to depression to pain, demonstrating the wide range of functions
 mediated by this receptor family. GPCR activation is determined not only by the initiation of signaling cascades but also
 by regulatory mechanisms that control the extent and duration of their signals. The balance of activation and desensitization
 dictate the ultimate physiological response to both endogenous and exogenous receptor stimuli. Therefore, these mechanisms
 may play a particularly relevant role during chronic exposure to agonists such as in conditions when drugs are abused. Two
 major classes of drugs of a...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795910</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:48 +0100</pubDate>
            <guid isPermaLink="false">795910</guid>        </item>
        <item>
            <title>Genes associated with addiction</title>
            <link>http://www.medworm.com/index.php?rid=795909&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe271l7q349785635%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Drug addiction is a complex disorder that has a large spectrum of causes. Vulnerability to addiction has been shown in twin
 studies to have a robust genetic component. This genetic basis for addiction has general and specific components for each
 drug abused. Although many genes have been implicated in drug addiction, only a handful have either been replicated to have
 an association or to have an identified functional mechanism related to specific effects of abused drugs. A few selected genetic
 variants that currently look promising for the study of alcohol, opiate, and cocaine addiction are discussed in this article.
 
	Content TypeJournal Article

	
		JournalNeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084
	
		Journal VolumeVolume 5
	
		Journal Issu...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795909</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:48 +0100</pubDate>
            <guid isPermaLink="false">795909</guid>        </item>
        <item>
            <title>Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders</title>
            <link>http://www.medworm.com/index.php?rid=795905&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp78834186741m086%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As in other cells, neurons use adenosine triphosphate (ATP) as an energy source to drive biochemical processes involved in
 various cell functions, and produce reactive oxygen species (ROS) as “by products” of oxidative phosphorylation. However,
 the electrical excitability and structural and synaptic complexity of neurons present unusual demands upon cellular systems
 that produce or respond to ATP and ROS. Mitochondria in axons and presynaptic terminals provide sources of ATP to drive the
 ion pumps that are concentrated in these structures to rapidly restore ion gradients following depolarization and neurotransmitter
 release. Mitochondria may also play important roles in the regulation of synaptic function because of their ability to regulate
 calcium levels and...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795905</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:48 +0100</pubDate>
            <guid isPermaLink="false">795905</guid>        </item>
        <item>
            <title>Bipolar disorder and schizophrenia</title>
            <link>http://www.medworm.com/index.php?rid=795914&amp;cid=s_36003_25_f&amp;fid=36003&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdq35684qv6326nx6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bipolar disorder (BPD) and schizophrenia (SZ) may have some common susceptibility genes, despite that current nosology separates
 them into nonoverlapping categories. The evidence for shared genetic factors includes epidemiologic characteristics, family
 studies, and overlap in confirmed linkages of BPD and/or SZ. Review of these data indicates that there are five genomic regions
 that may represent shared genetic susceptibility of BPD and SZ. As the genes underlying these confirmed linkages are identified,
 the current nosology must be changed to reflect the new knowledge concerning the shared etiologies of BPD and SZ.
 
	Content TypeJournal Article

	
		JournalNeuroMolecular MedicineOnline ISSN 1559-1174Print ISSN 1535-1084
	
		Journal VolumeVolume 5
	
		Journal Issue...</description>
            <author>NeuroMolecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=795914</comments>
            <pubDate>Wed, 08 Aug 2007 06:53:47 +0100</pubDate>
            <guid isPermaLink="false">795914</guid>        </item>
    </channel>
</rss>
